{
  "lectures": [
    {
      "topic": "Introduction to Neoplasia",
      "subtopics": [
        {
          "name": "Papillomas: Histologic Pattern vs Site",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L1_Q12",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 38-year-old woman presents with a thyroid nodule. Biopsy shows papillary structures lined by malignant epithelial cells, with nuclear clearing and psammoma bodies. Which diagnosis is most likely?",
              "options": {
                "A": "Follicular adenoma",
                "B": "Papillary thyroid carcinoma",
                "C": "Medullary thyroid carcinoma",
                "D": "Anaplastic carcinoma",
                "E": "Thyroglossal duct cyst"
              },
              "answer": "B",
              "explanation": "Papillary thyroid carcinoma shows papillary fronds, Orphan Annie nuclei, and psammoma bodies.",
              "image": null
            },
            {
              "stem": "A case is suspected to involve Papillomas: Histologic Pattern vs Site within the broader topic of Introduction to Neoplasia. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Serum tumor markers alone establish diagnosis",
                "B": "Reliance on imaging alone",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Exclusion of biopsy to avoid tumor spread"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "A case is suspected to involve Papillomas: Histologic Pattern vs Site within the broader topic of Introduction to Neoplasia. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Serum tumor markers alone establish diagnosis",
                "B": "Reliance on imaging alone",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Exclusion of biopsy to avoid tumor spread"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Adenocarcinoma and Differentiation Spectrum",
          "question_count": 4,
          "long_questions": [
            {
              "id": "L1_Q3",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 68-year-old smoker has a lung nodule. Biopsy reveals poorly differentiated malignant cells with rare gland formation, nuclear pleomorphism, and abnormal mitoses. Which of the following best describes this tumor?",
              "options": {
                "A": "Well-differentiated adenocarcinoma",
                "B": "Poorly differentiated adenocarcinoma",
                "C": "Squamous cell carcinoma in situ",
                "D": "Hamartoma",
                "E": "Small cell carcinoma"
              },
              "answer": "B",
              "explanation": "Poorly differentiated adenocarcinomas lack glandular architecture, exhibit pleomorphism, and abnormal mitotic figures.",
              "image": null
            },
            {
              "id": "L1_Q5",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 62-year-old man undergoes colectomy for colon cancer. The tumor forms glands resembling colonic mucosa, with only mild atypia and low mitotic activity. Which term best applies?",
              "options": {
                "A": "Well-differentiated adenocarcinoma",
                "B": "Moderately differentiated adenocarcinoma",
                "C": "Poorly differentiated adenocarcinoma",
                "D": "Carcinoma in situ",
                "E": "Hamartoma"
              },
              "answer": "A",
              "explanation": "Well-differentiated tumors closely resemble normal tissue. Poorly differentiated tumors have little resemblance to tissue of origin.",
              "image": null
            },
            {
              "id": "L1_Q19",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 50-year-old man presents with a rapidly enlarging neck mass. Histology shows sheets of undifferentiated malignant cells with giant cells, necrosis, and numerous mitoses. Which thyroid carcinoma is most likely?",
              "options": {
                "A": "Papillary carcinoma",
                "B": "Follicular carcinoma",
                "C": "Medullary carcinoma",
                "D": "Anaplastic carcinoma",
                "E": "Hurthle cell adenoma"
              },
              "answer": "D",
              "explanation": "Anaplastic carcinoma is highly aggressive, undifferentiated, with giant cells and poor prognosis.",
              "image": null
            },
            {
              "id": "L1_Q20",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 59-year-old woman with colon carcinoma undergoes resection. Histology shows malignant glands with marked atypia, little resemblance to colonic mucosa, and frequent mitoses. Which is the best description?",
              "options": {
                "A": "Well-differentiated adenocarcinoma",
                "B": "Moderately differentiated adenocarcinoma",
                "C": "Poorly differentiated adenocarcinoma",
                "D": "Carcinoma in situ",
                "E": "Hamartoma"
              },
              "answer": "C",
              "explanation": "Poorly differentiated adenocarcinomas show little resemblance to normal tissue and have aggressive features.",
              "image": null
            }
          ]
        },
        {
          "name": "Dysplasia and Carcinoma in Situ",
          "question_count": 6,
          "long_questions": [
            {
              "id": "L1_Q2",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 42-year-old man undergoes cystoscopy for hematuria. A papillary lesion is excised and histology shows fibrovascular cores lined by normal-appearing urothelium, with an intact basement membrane. What is the best diagnosis?",
              "options": {
                "A": "Invasive urothelial carcinoma",
                "B": "Urothelial carcinoma in situ",
                "C": "Urothelial papilloma",
                "D": "Dysplasia",
                "E": "Adenocarcinoma"
              },
              "answer": "C",
              "explanation": "Papilloma is benign: orderly architecture and intact basement membrane. CIS is flat with marked atypia. Invasive carcinoma breaches the basement membrane.",
              "image": null
            },
            {
              "id": "L1_Q4",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 36-year-old woman has a cervical lesion. Biopsy reveals full-thickness epithelial atypia with loss of polarity and increased mitoses, but the basement membrane is intact. What is the most appropriate diagnosis?",
              "options": {
                "A": "Dysplasia",
                "B": "Carcinoma in situ",
                "C": "Invasive carcinoma",
                "D": "Metaplasia",
                "E": "Hyperplasia"
              },
              "answer": "B",
              "explanation": "Carcinoma in situ involves full-thickness atypia without invasion past the basement membrane. Dysplasia is partial thickness.",
              "image": null
            },
            {
              "id": "L1_Q10",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 46-year-old woman undergoes biopsy of a cervical lesion. Atypical cells are confined to the lower third of the squamous epithelium. The basement membrane is intact. Which of the following best describes this lesion?",
              "options": {
                "A": "Mild dysplasia",
                "B": "Moderate dysplasia",
                "C": "Severe dysplasia",
                "D": "Carcinoma in situ",
                "E": "Invasive carcinoma"
              },
              "answer": "A",
              "explanation": "Mild dysplasia involves atypia in the lower third of the epithelium. CIS involves full thickness atypia.",
              "image": null
            },
            {
              "id": "L1_Q13",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 70-year-old man has a gastric tumor that appears well circumscribed and encapsulated. Histology shows uniform cells with little atypia and no necrosis. Which is the best classification?",
              "options": {
                "A": "Benign tumor",
                "B": "Carcinoma in situ",
                "C": "Invasive carcinoma",
                "D": "Sarcoma",
                "E": "Lymphoma"
              },
              "answer": "A",
              "explanation": "Benign tumors are well circumscribed, encapsulated, and lack cytologic atypia or necrosis.",
              "image": null
            },
            {
              "id": "L1_Q16",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 65-year-old woman undergoes biopsy of an esophageal lesion. Histology shows disordered squamous epithelium with atypia confined to the middle third of the epithelium. Which diagnosis is most likely?",
              "options": {
                "A": "Mild dysplasia",
                "B": "Moderate dysplasia",
                "C": "Severe dysplasia",
                "D": "Carcinoma in situ",
                "E": "Invasive carcinoma"
              },
              "answer": "B",
              "explanation": "Moderate dysplasia involves atypia in the lower two-thirds of the epithelium. Severe dysplasia involves almost full thickness atypia.",
              "image": null
            },
            {
              "id": "L1_Q17",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 72-year-old woman undergoes biopsy of a vulvar lesion. Histology shows full-thickness squamous atypia with mitotic figures, intact basement membrane. Which best describes this lesion?",
              "options": {
                "A": "Mild dysplasia",
                "B": "Moderate dysplasia",
                "C": "Severe dysplasia",
                "D": "Carcinoma in situ",
                "E": "Invasive carcinoma"
              },
              "answer": "D",
              "explanation": "Carcinoma in situ = full-thickness atypia without invasion past the basement membrane.",
              "image": null
            }
          ]
        },
        {
          "name": "Leiomyoma (Benign Smooth Muscle Tumor)",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L1_Q1",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 55-year-old woman presents with abdominal fullness and postmenopausal bleeding. Imaging reveals a large uterine mass. Biopsy shows spindle cells with marked nuclear pleomorphism, frequent mitoses, and tumor necrosis. Which of the following is the most likely diagnosis?",
              "options": {
                "A": "Endometrial hyperplasia",
                "B": "Leiomyoma",
                "C": "Leiomyosarcoma",
                "D": "Endometriosis",
                "E": "Fibroadenoma"
              },
              "answer": "C",
              "explanation": "Leiomyosarcoma is malignant: high mitotic activity, necrosis, and nuclear pleomorphism. Leiomyomas are benign, lack atypia, and are well-circumscribed.",
              "image": null
            },
            {
              "stem": "A 34-year-old with menorrhagia has a uterine mass. Histology is consistent with Leiomyoma (Benign Smooth Muscle Tumor). Which feature supports a benign lesion?",
              "options": {
                "A": "Infiltrative border with high mitotic index",
                "B": "Well\u2011circumscribed whorled mass with low mitotic activity",
                "C": "Marked atypia and tumor necrosis",
                "D": "Nuclear pleomorphism and atypical mitoses"
              },
              "answer": "B",
              "explanation": "Leiomyoma is benign; leiomyosarcoma shows atypia, necrosis, and high mitoses.",
              "difficulty": "medium"
            },
            {
              "stem": "A 34-year-old with menorrhagia has a uterine mass. Histology is consistent with Leiomyoma (Benign Smooth Muscle Tumor). Which feature supports a benign lesion?",
              "options": {
                "A": "Infiltrative border with high mitotic index",
                "B": "Well\u2011circumscribed whorled mass with low mitotic activity",
                "C": "Marked atypia and tumor necrosis",
                "D": "Nuclear pleomorphism and atypical mitoses"
              },
              "answer": "B",
              "explanation": "Leiomyoma is benign; leiomyosarcoma shows atypia, necrosis, and high mitoses.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Carcinoma in Situ vs Invasive Carcinoma",
          "question_count": 2,
          "long_questions": [
            {
              "id": "L1_Q7",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 59-year-old woman undergoes lumpectomy for ductal carcinoma. Pathology shows malignant epithelial cells confined within ducts and lobules with intact basement membrane. What is the correct diagnosis?",
              "options": {
                "A": "Invasive ductal carcinoma",
                "B": "Carcinoma in situ",
                "C": "Adenoma",
                "D": "Metastasis",
                "E": "Sarcoma"
              },
              "answer": "B",
              "explanation": "Carcinoma in situ has malignant cells confined by the basement membrane. Invasion occurs once the basement membrane is breached.",
              "image": null
            },
            {
              "id": "L1_Q11",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 62-year-old man with prostate carcinoma undergoes resection. Histology shows back-to-back malignant glands with nuclear atypia and frequent mitoses. The basement membrane is breached. Which best describes the diagnosis?",
              "options": {
                "A": "Prostatic intraepithelial neoplasia",
                "B": "Adenoma",
                "C": "Invasive adenocarcinoma",
                "D": "Carcinoma in situ",
                "E": "Hyperplasia"
              },
              "answer": "C",
              "explanation": "Invasive carcinoma breaches the basement membrane, unlike carcinoma in situ.",
              "image": null
            }
          ]
        },
        {
          "name": "Metastasis and Routes of Spread",
          "question_count": 6,
          "long_questions": [
            {
              "id": "L1_Q6",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 70-year-old man with hepatocellular carcinoma is found to have tumor thrombus in the hepatic vein extending into the inferior vena cava. Which is the most likely route of spread?",
              "options": {
                "A": "Lymphatic spread",
                "B": "Direct extension",
                "C": "Hematogenous spread",
                "D": "Seeding of body cavity",
                "E": "Perineural invasion"
              },
              "answer": "C",
              "explanation": "Hepatocellular carcinoma commonly spreads hematogenously via hepatic veins to the lungs.",
              "image": null
            },
            {
              "id": "L1_Q8",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 73-year-old woman with ovarian carcinoma presents with abdominal distention. CT scan shows multiple peritoneal implants. Which mechanism of spread is most likely?",
              "options": {
                "A": "Hematogenous spread",
                "B": "Lymphatic spread",
                "C": "Direct seeding of body cavities",
                "D": "Perineural invasion",
                "E": "Retrograde venous spread"
              },
              "answer": "C",
              "explanation": "Ovarian carcinomas frequently metastasize by seeding the peritoneum.",
              "image": null
            },
            {
              "id": "L1_Q9",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 51-year-old man with a lung carcinoma presents with seizures. Brain MRI shows multiple ring-enhancing lesions. Which is the most likely route of metastasis?",
              "options": {
                "A": "Direct extension",
                "B": "Hematogenous spread",
                "C": "Lymphatic spread",
                "D": "Seeding of body cavity",
                "E": "Perineural spread"
              },
              "answer": "B",
              "explanation": "Lung carcinomas often spread hematogenously to the brain, adrenal glands, and bone.",
              "image": null
            },
            {
              "id": "L1_Q14",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 60-year-old woman with breast carcinoma develops enlarged axillary lymph nodes. Biopsy confirms metastatic carcinoma. What route of spread is most likely?",
              "options": {
                "A": "Lymphatic",
                "B": "Hematogenous",
                "C": "Seeding",
                "D": "Direct extension",
                "E": "Perineural"
              },
              "answer": "A",
              "explanation": "Carcinomas commonly spread via lymphatics, as in breast cancer metastasis to axillary nodes.",
              "image": null
            },
            {
              "id": "L1_Q15",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 55-year-old man with renal cell carcinoma is found to have a lytic lesion in the femur. What route of metastasis explains this finding?",
              "options": {
                "A": "Lymphatic",
                "B": "Direct extension",
                "C": "Hematogenous",
                "D": "Seeding of body cavity",
                "E": "Perineural spread"
              },
              "answer": "C",
              "explanation": "Renal cell carcinoma commonly metastasizes hematogenously to bone and lung.",
              "image": null
            },
            {
              "id": "L1_Q18",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 48-year-old man with chronic hepatitis develops a liver mass. Histology shows trabeculae of malignant hepatocytes invading portal tracts and sinusoids. Which is the most likely diagnosis?",
              "options": {
                "A": "Hepatic adenoma",
                "B": "Hepatocellular carcinoma",
                "C": "Metastasis",
                "D": "Cholangiocarcinoma",
                "E": "Focal nodular hyperplasia"
              },
              "answer": "B",
              "explanation": "Hepatocellular carcinoma arises in cirrhosis and shows malignant hepatocytes invading hepatic structures.",
              "image": null
            }
          ]
        },
        {
          "name": "Normal Tissue vs Anaplasia",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Normal Tissue vs Anaplasia within the broader topic of Introduction to Neoplasia. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Integration of histology with molecular testing correlating with clinical context",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Exclusion of biopsy to avoid tumor spread"
              },
              "answer": "B",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Normal Tissue vs Anaplasia, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Presence of inflammation",
                "B": "Patient age alone",
                "C": "Evidence of invasion and metastatic potential",
                "D": "Lesion size alone"
              },
              "answer": "C",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Leiomyosarcoma (Malignant Smooth Muscle Tumor)",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Leiomyosarcoma (Malignant Smooth Muscle Tumor) within the broader topic of Introduction to Neoplasia. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Leiomyosarcoma (Malignant Smooth Muscle Tumor), which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Presence of inflammation",
                "B": "Evidence of invasion and metastatic potential",
                "C": "Patient age alone",
                "D": "Lesion size alone"
              },
              "answer": "B",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Tumor Margins: Benign vs Malignant",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Tumor Margins: Benign vs Malignant within the broader topic of Introduction to Neoplasia. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Tumor Margins: Benign vs Malignant, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Lesion size alone",
                "B": "Presence of inflammation",
                "C": "Patient age alone",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        }
      ]
    },
    {
      "topic": "Genetic Testing for Familial Cancer Syndromes",
      "subtopics": [
        {
          "name": "Sporadic, Familial, and Hereditary Cancer",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L2_Q17",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 39-year-old woman presents with a family history of melanoma and pancreatic cancer. Genetic testing shows a CDKN2A mutation. Which protein is lost?",
              "options": {
                "A": "p16",
                "B": "p53",
                "C": "Rb",
                "D": "APC",
                "E": "BRCA1"
              },
              "answer": "A",
              "explanation": "CDKN2A encodes p16 (cyclin-dependent kinase inhibitor). Mutation predisposes to melanoma and pancreatic carcinoma.",
              "image": null
            },
            {
              "stem": "A case is suspected to involve Sporadic, Familial, and Hereditary Cancer within the broader topic of Genetic Testing for Familial Cancer Syndromes. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "A case is suspected to involve Sporadic, Familial, and Hereditary Cancer within the broader topic of Genetic Testing for Familial Cancer Syndromes. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Oncogenes vs Tumor Suppressor Genes",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L2_Q4",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 7-year-old boy presents with leukocoria. His father also had a history of retinoblastoma. Which genetic mechanism explains this inheritance?",
              "options": {
                "A": "Oncogene activation",
                "B": "Single somatic mutation",
                "C": "Two-hit inactivation of a tumor suppressor gene",
                "D": "Mitochondrial mutation",
                "E": "Epigenetic silencing of an oncogene"
              },
              "answer": "C",
              "explanation": "Retinoblastoma follows the two-hit hypothesis: both alleles of RB1 must be inactivated. Germline mutation predisposes to bilateral disease.",
              "image": null
            },
            {
              "stem": "A case is suspected to involve Oncogenes vs Tumor Suppressor Genes within the broader topic of Genetic Testing for Familial Cancer Syndromes. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Reliance on imaging alone",
                "D": "Exclusion of biopsy to avoid tumor spread"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "A case is suspected to involve Oncogenes vs Tumor Suppressor Genes within the broader topic of Genetic Testing for Familial Cancer Syndromes. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Reliance on imaging alone",
                "D": "Exclusion of biopsy to avoid tumor spread"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Pathways Targeted by Hereditary Syndromes",
          "question_count": 6,
          "long_questions": [
            {
              "id": "L2_Q5",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 40-year-old man with multiple caf\u00e9-au-lait spots, axillary freckling, and cutaneous neurofibromas is found to carry a mutation in NF1. Which pathway is dysregulated?",
              "options": {
                "A": "Wnt/\u03b2-catenin",
                "B": "RAS/MAPK signaling",
                "C": "p53-mediated apoptosis",
                "D": "Mismatch repair",
                "E": "Telomerase activity"
              },
              "answer": "B",
              "explanation": "NF1 is a tumor suppressor gene that negatively regulates RAS/MAPK signaling. Loss leads to uncontrolled proliferation.",
              "image": null
            },
            {
              "id": "L2_Q9",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 12-year-old boy presents with bilateral renal cell carcinoma. Genetic testing reveals a germline mutation in VHL. Which cellular process is most directly dysregulated?",
              "options": {
                "A": "DNA mismatch repair",
                "B": "Homologous recombination",
                "C": "Ubiquitin-mediated degradation of HIF-1\u03b1",
                "D": "Wnt signaling",
                "E": "Telomerase activation"
              },
              "answer": "C",
              "explanation": "VHL normally regulates degradation of HIF-1\u03b1. Mutation leads to \u2191 HIF \u2192 angiogenesis and tumorigenesis.",
              "image": null
            },
            {
              "id": "L2_Q10",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 41-year-old woman with family history of thyroid cancer is found to carry a RET mutation. Which syndrome does this most likely represent?",
              "options": {
                "A": "MEN1",
                "B": "MEN2A/2B",
                "C": "Lynch syndrome",
                "D": "Li-Fraumeni syndrome",
                "E": "Cowden syndrome"
              },
              "answer": "B",
              "explanation": "RET proto-oncogene mutations cause MEN2 syndromes (medullary thyroid carcinoma, pheochromocytoma, parathyroid hyperplasia or mucosal neuromas).",
              "image": null
            },
            {
              "id": "L2_Q12",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 33-year-old man with a family history of thyroid nodules and mucosal neuromas is diagnosed with medullary thyroid carcinoma. Which mutation is most likely?",
              "options": {
                "A": "APC",
                "B": "RET",
                "C": "BRCA2",
                "D": "TP53",
                "E": "MSH2"
              },
              "answer": "B",
              "explanation": "MEN2B due to RET mutations \u2192 medullary thyroid carcinoma, pheochromocytoma, mucosal neuromas, marfanoid habitus.",
              "image": null
            },
            {
              "id": "L2_Q15",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 48-year-old man with a family history of hamartomatous polyps and macrocephaly is found to carry a PTEN mutation. What syndrome does this represent?",
              "options": {
                "A": "Cowden syndrome",
                "B": "Lynch syndrome",
                "C": "FAP",
                "D": "Peutz-Jeghers",
                "E": "Li-Fraumeni"
              },
              "answer": "A",
              "explanation": "Cowden syndrome (PTEN mutation) involves hamartomas, macrocephaly, and \u2191 breast, thyroid, endometrial cancers.",
              "image": null
            },
            {
              "id": "L2_Q16",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 19-year-old boy presents with caf\u00e9-au-lait spots and bilateral vestibular schwannomas. Which mutation is responsible?",
              "options": {
                "A": "NF1",
                "B": "NF2",
                "C": "VHL",
                "D": "TP53",
                "E": "MSH2"
              },
              "answer": "B",
              "explanation": "NF2 mutation \u2192 bilateral vestibular schwannomas, meningiomas, ependymomas.",
              "image": null
            }
          ]
        },
        {
          "name": "Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L2_Q3",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 54-year-old man with a family history of colon and endometrial cancers is diagnosed with right-sided colon cancer. Genetic testing reveals an MSH2 mutation. Which syndrome does this represent?",
              "options": {
                "A": "Familial adenomatous polyposis",
                "B": "Lynch syndrome",
                "C": "Peutz-Jeghers syndrome",
                "D": "Li-Fraumeni syndrome",
                "E": "Cowden syndrome"
              },
              "answer": "B",
              "explanation": "Lynch syndrome (HNPCC) involves germline mutations in DNA mismatch repair genes (MLH1, MSH2, MSH6, PMS2). Associated with CRC, endometrial, ovarian cancers.",
              "image": null
            },
            {
              "id": "L2_Q11",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 58-year-old woman with breast carcinoma undergoes genetic testing. A pathogenic CHEK2 mutation is identified. What is the function of this gene?",
              "options": {
                "A": "Mismatch repair",
                "B": "DNA damage checkpoint kinase",
                "C": "RAS pathway inhibitor",
                "D": "Telomerase regulator",
                "E": "Wnt pathway suppressor"
              },
              "answer": "B",
              "explanation": "CHEK2 encodes a checkpoint kinase important for DNA damage signaling and repair.",
              "image": null
            },
            {
              "id": "L2_Q13",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 46-year-old woman presents with colon cancer. Genetic testing shows MSI-H. Which therapeutic approach may be most effective?",
              "options": {
                "A": "PARP inhibitors",
                "B": "Checkpoint inhibitors (PD-1 blockade)",
                "C": "Platinum chemotherapy",
                "D": "Anti-VEGF therapy",
                "E": "Tyrosine kinase inhibitors"
              },
              "answer": "B",
              "explanation": "MSI-H tumors (e.g., Lynch syndrome) often respond well to immune checkpoint blockade.",
              "image": null
            }
          ]
        },
        {
          "name": "Familial Adenomatous Polyposis (FAP)",
          "question_count": 6,
          "long_questions": [
            {
              "id": "L2_Q2",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 27-year-old man presents with hundreds of colonic polyps on colonoscopy. Genetic testing reveals a germline mutation in APC. Which of the following is the most appropriate management?",
              "options": {
                "A": "Annual colonoscopy surveillance only",
                "B": "Colectomy",
                "C": "Chemotherapy",
                "D": "Aspirin prophylaxis only",
                "E": "Observation until age 50"
              },
              "answer": "B",
              "explanation": "FAP (APC mutation) carries near 100% risk of colon cancer, requiring prophylactic colectomy.",
              "image": null
            },
            {
              "id": "L2_Q6",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 37-year-old man presents with mucocutaneous pigmentation and hamartomatous polyps in the small intestine. Genetic testing reveals a mutation in STK11. What syndrome does he have?",
              "options": {
                "A": "Lynch syndrome",
                "B": "Peutz-Jeghers syndrome",
                "C": "Cowden syndrome",
                "D": "FAP",
                "E": "Li-Fraumeni syndrome"
              },
              "answer": "B",
              "explanation": "Peutz-Jeghers syndrome: hamartomatous polyps + mucocutaneous pigmentation. STK11 mutation, \u2191 risk GI and pancreatic cancers.",
              "image": null
            },
            {
              "id": "L2_Q7",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 25-year-old man presents with jaw osteomas, epidermoid cysts, and numerous colonic polyps. Which hereditary syndrome is most consistent?",
              "options": {
                "A": "Lynch syndrome",
                "B": "FAP (Gardner variant)",
                "C": "Peutz-Jeghers syndrome",
                "D": "Li-Fraumeni syndrome",
                "E": "Cowden syndrome"
              },
              "answer": "B",
              "explanation": "Gardner variant of FAP includes APC mutation with colonic polyps, osteomas, epidermoid cysts, and dental abnormalities.",
              "image": null
            },
            {
              "id": "L2_Q8",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 45-year-old woman with early-onset breast cancer is found to carry a TP53 mutation. What is her syndrome called?",
              "options": {
                "A": "Li-Fraumeni syndrome",
                "B": "Cowden syndrome",
                "C": "Lynch syndrome",
                "D": "Peutz-Jeghers syndrome",
                "E": "FAP"
              },
              "answer": "A",
              "explanation": "Li-Fraumeni syndrome: germline TP53 mutation \u2192 breast, sarcomas, brain tumors, leukemias, adrenocortical carcinoma.",
              "image": null
            },
            {
              "id": "L2_Q14",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 60-year-old woman presents with multiple basal cell carcinomas. She is found to carry a PTCH1 mutation. Which pathway is dysregulated?",
              "options": {
                "A": "Hedgehog signaling",
                "B": "Wnt/\u03b2-catenin",
                "C": "RAS/MAPK",
                "D": "PI3K/AKT",
                "E": "p53"
              },
              "answer": "A",
              "explanation": "PTCH1 mutations cause Gorlin syndrome (nevoid basal cell carcinoma syndrome), linked to abnormal Hedgehog signaling.",
              "image": null
            },
            {
              "id": "L2_Q18",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 45-year-old man with multiple endocrine tumors is found to carry a MEN1 mutation. Which protein is defective?",
              "options": {
                "A": "p53",
                "B": "Menin",
                "C": "PTEN",
                "D": "NF1",
                "E": "Rb"
              },
              "answer": "B",
              "explanation": "MEN1 gene encodes menin, a tumor suppressor. Loss predisposes to pituitary, pancreatic, and parathyroid tumors.",
              "image": null
            }
          ]
        },
        {
          "name": "Hereditary Breast and Ovarian Cancer (HBOC)",
          "question_count": 2,
          "long_questions": [
            {
              "id": "L2_Q1",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 32-year-old woman with a strong family history of breast cancer undergoes genetic testing and is found to carry a pathogenic BRCA1 mutation. Which mechanism underlies her increased cancer risk?",
              "options": {
                "A": "Defective mismatch repair",
                "B": "Defective homologous recombination repair",
                "C": "Defective nucleotide excision repair",
                "D": "Oncogene activation",
                "E": "Increased telomerase activity"
              },
              "answer": "B",
              "explanation": "BRCA1/2 mutations impair homologous recombination DNA repair, predisposing to breast, ovarian, prostate, and pancreatic cancers.",
              "image": null
            },
            {
              "id": "L2_Q19",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 35-year-old woman presents with ovarian cancer. Her family history includes multiple relatives with breast cancer. Genetic testing reveals a PALB2 mutation. Which pathway is impaired?",
              "options": {
                "A": "Mismatch repair",
                "B": "Homologous recombination repair",
                "C": "Base excision repair",
                "D": "Nucleotide excision repair",
                "E": "Telomere elongation"
              },
              "answer": "B",
              "explanation": "PALB2 works with BRCA2 in homologous recombination repair. Mutations predispose to breast, ovarian, pancreatic cancers.",
              "image": null
            }
          ]
        },
        {
          "name": "Genetic vs Epigenetic Changes",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Genetic vs Epigenetic Changes within the broader topic of Genetic Testing for Familial Cancer Syndromes. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Serum tumor markers alone establish diagnosis",
                "B": "Integration of histology with molecular testing correlating with clinical context",
                "C": "Reliance on imaging alone",
                "D": "Exclusion of biopsy to avoid tumor spread"
              },
              "answer": "B",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Genetic vs Epigenetic Changes, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Presence of inflammation",
                "B": "Lesion size alone",
                "C": "Patient age alone",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Germline vs Somatic Mutations",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Germline vs Somatic Mutations within the broader topic of Genetic Testing for Familial Cancer Syndromes. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Serum tumor markers alone establish diagnosis",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Reliance on imaging alone"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Germline vs Somatic Mutations, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Lesion size alone",
                "B": "Presence of inflammation",
                "C": "Evidence of invasion and metastatic potential",
                "D": "Patient age alone"
              },
              "answer": "C",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Second-Hit Hypothesis",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Second-Hit Hypothesis within the broader topic of Genetic Testing for Familial Cancer Syndromes. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Serum tumor markers alone establish diagnosis",
                "B": "Integration of histology with molecular testing correlating with clinical context",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Reliance on imaging alone"
              },
              "answer": "B",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Second-Hit Hypothesis, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Presence of inflammation",
                "B": "Lesion size alone",
                "C": "Patient age alone",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Genetic Test Result Categories",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Genetic Test Result Categories within the broader topic of Genetic Testing for Familial Cancer Syndromes. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Reliance on imaging alone",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Genetic Test Result Categories, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Lesion size alone",
                "B": "Evidence of invasion and metastatic potential",
                "C": "Presence of inflammation",
                "D": "Patient age alone"
              },
              "answer": "B",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        }
      ]
    },
    {
      "topic": "Molecular Diagnostics",
      "subtopics": [
        {
          "name": "Isolation of Nucleic Acids",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L3_Q11",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 46-year-old woman with suspected ovarian cancer undergoes liquid biopsy. Which biomarker is most likely analyzed in her blood sample?",
              "options": {
                "A": "Circulating tumor DNA",
                "B": "Circulating red blood cells",
                "C": "Serum sodium concentration",
                "D": "Mitochondrial DNA",
                "E": "Chromatin proteins"
              },
              "answer": "A",
              "explanation": "Liquid biopsies detect circulating tumor DNA, allowing noninvasive cancer monitoring.",
              "image": null
            },
            {
              "id": "L3_Q15",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 41-year-old woman with suspected breast cancer recurrence undergoes immunohistochemistry for HER2. What would overexpression of HER2 suggest?",
              "options": {
                "A": "Favorable prognosis",
                "B": "No clinical significance",
                "C": "Aggressive tumor with potential response to trastuzumab",
                "D": "Associated with Lynch syndrome",
                "E": "Indicates BRCA mutation"
              },
              "answer": "C",
              "explanation": "HER2 overexpression is associated with aggressive tumors but predicts responsiveness to trastuzumab.",
              "image": null
            },
            {
              "id": "L3_Q19",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 56-year-old woman with a family history of ovarian cancer undergoes germline BRCA1 testing. Her report shows a variant of uncertain significance (VUS). How should this result be managed clinically?",
              "options": {
                "A": "Treat as pathogenic",
                "B": "Treat as benign",
                "C": "Do not use for management until reclassified",
                "D": "Prophylactic surgery immediately",
                "E": "Ignore result"
              },
              "answer": "C",
              "explanation": "VUS should not guide management until sufficient evidence reclassifies it as pathogenic or benign.",
              "image": null
            }
          ]
        },
        {
          "name": "Reverse Transcription and cDNA",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L3_Q7",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 7-year-old boy with X-linked SCID undergoes gene therapy. A retroviral vector inserts the therapeutic gene into his T-cells. What is the main risk of this therapy?",
              "options": {
                "A": "Immune rejection",
                "B": "Insertional mutagenesis",
                "C": "Mosaicism",
                "D": "Autoimmune reaction",
                "E": "Incomplete penetrance"
              },
              "answer": "B",
              "explanation": "Retroviral vectors can integrate near proto-oncogenes, causing insertional mutagenesis and leukemia.",
              "image": null
            },
            {
              "stem": "A case is suspected to involve Reverse Transcription and cDNA within the broader topic of Molecular Diagnostics. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Reliance on imaging alone",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Exclusion of biopsy to avoid tumor spread"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "A case is suspected to involve Reverse Transcription and cDNA within the broader topic of Molecular Diagnostics. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Reliance on imaging alone",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Exclusion of biopsy to avoid tumor spread"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Transfection vs Transduction",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L3_Q9",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 10-year-old boy with severe immunodeficiency has ADA deficiency. Gene therapy is attempted using a lentiviral vector. Compared to retroviruses, what is the main advantage of lentiviral vectors?",
              "options": {
                "A": "Infect dividing and non-dividing cells",
                "B": "Do not integrate into host genome",
                "C": "Carry larger genes than retroviruses",
                "D": "Avoid immune responses",
                "E": "Provide germline modification"
              },
              "answer": "A",
              "explanation": "Lentiviruses infect both dividing and non-dividing cells, unlike retroviruses which only infect dividing cells.",
              "image": null
            },
            {
              "stem": "A case is suspected to involve Transfection vs Transduction within the broader topic of Molecular Diagnostics. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Reliance on imaging alone",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "A case is suspected to involve Transfection vs Transduction within the broader topic of Molecular Diagnostics. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Reliance on imaging alone",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Polymerase Chain Reaction (PCR)",
          "question_count": 2,
          "long_questions": [
            {
              "id": "L3_Q5",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 40-year-old woman with melanoma undergoes BRAF mutation testing. The diagnostic test requires amplification of specific DNA regions using short oligonucleotide primers. Which method is this?",
              "options": {
                "A": "PCR",
                "B": "Northern blot",
                "C": "Western blot",
                "D": "ELISA",
                "E": "Flow cytometry"
              },
              "answer": "A",
              "explanation": "PCR amplifies specific DNA regions for downstream mutation analysis.",
              "image": null
            },
            {
              "id": "L3_Q14",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 62-year-old man with chronic myeloid leukemia undergoes qRT-PCR monitoring for BCR-ABL transcript levels. What is the primary advantage of qRT-PCR in this context?",
              "options": {
                "A": "Detects gene amplification",
                "B": "Provides quantitative measurement of transcript levels",
                "C": "Detects protein products",
                "D": "Measures DNA methylation",
                "E": "Identifies germline variants"
              },
              "answer": "B",
              "explanation": "qRT-PCR quantifies transcript levels, useful for monitoring disease burden in CML.",
              "image": null
            }
          ]
        },
        {
          "name": "Blotting Techniques",
          "question_count": 5,
          "long_questions": [
            {
              "id": "L3_Q2",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 32-year-old man with suspected chronic myelogenous leukemia undergoes a molecular diagnostic test to detect the BCR-ABL fusion transcript. The test uses fluorescent probes that hybridize to specific sequences. Which method is most appropriate?",
              "options": {
                "A": "Western blotting",
                "B": "FISH",
                "C": "PCR",
                "D": "Karyotyping",
                "E": "Southern blotting"
              },
              "answer": "B",
              "explanation": "FISH uses fluorescent probes to detect gene rearrangements like BCR-ABL fusion on the Philadelphia chromosome.",
              "image": null
            },
            {
              "id": "L3_Q3",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 29-year-old man with suspected Duchenne muscular dystrophy undergoes molecular testing. The diagnostic technique uses a radiolabeled DNA probe that hybridizes to specific DNA fragments after restriction enzyme digestion and gel electrophoresis. Which method is this?",
              "options": {
                "A": "Northern blot",
                "B": "Southern blot",
                "C": "Western blot",
                "D": "PCR",
                "E": "Immunohistochemistry"
              },
              "answer": "B",
              "explanation": "Southern blot detects specific DNA sequences using radiolabeled probes after restriction digestion.",
              "image": null
            },
            {
              "id": "L3_Q4",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 50-year-old man with suspected Fragile X syndrome undergoes a molecular diagnostic test. The method detects CGG repeat expansions in the FMR1 gene. Which method is most commonly used?",
              "options": {
                "A": "PCR with capillary electrophoresis",
                "B": "Northern blotting",
                "C": "Sanger sequencing",
                "D": "Immunohistochemistry",
                "E": "Western blotting"
              },
              "answer": "A",
              "explanation": "Repeat expansions are detected using PCR and capillary electrophoresis or Southern blot for very large repeats.",
              "image": null
            },
            {
              "id": "L3_Q8",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 35-year-old woman undergoes a diagnostic test to assess gene expression levels in her breast cancer biopsy. The test involves immobilized cDNA sequences that hybridize with fluorescently labeled mRNA. Which test is this?",
              "options": {
                "A": "Southern blot",
                "B": "Western blot",
                "C": "DNA microarray",
                "D": "Sanger sequencing",
                "E": "PCR"
              },
              "answer": "C",
              "explanation": "Microarrays detect and quantify mRNA expression patterns in tissues.",
              "image": null
            },
            {
              "id": "L3_Q12",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 52-year-old man undergoes a diagnostic test for p53 protein expression. Tumor lysates are separated by gel electrophoresis, transferred to a membrane, and probed with antibodies. Which technique is this?",
              "options": {
                "A": "Southern blot",
                "B": "Western blot",
                "C": "Northern blot",
                "D": "FISH",
                "E": "PCR"
              },
              "answer": "B",
              "explanation": "Western blot detects specific proteins using antibodies.",
              "image": null
            }
          ]
        },
        {
          "name": "Sanger Sequencing",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L3_Q10",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 58-year-old man with lung cancer undergoes molecular testing for EGFR mutations. The laboratory uses a chain-termination sequencing method involving ddNTPs. Which sequencing method is this?",
              "options": {
                "A": "Next-generation sequencing",
                "B": "Sanger sequencing",
                "C": "Southern blot",
                "D": "FISH",
                "E": "PCR"
              },
              "answer": "B",
              "explanation": "Sanger sequencing uses chain-terminating ddNTPs to identify DNA sequences.",
              "image": null
            },
            {
              "stem": "A broad NGS panel is ordered for a lung adenocarcinoma. Compared with single\u2011gene Sanger Sequencing, what is the main advantage?",
              "options": {
                "A": "Cannot detect gene fusions",
                "B": "Direct measurement of protein phosphorylation states",
                "C": "Simultaneous detection of SNVs, indels, fusions, CNVs across many genes",
                "D": "Lower depth but faster than PCR"
              },
              "answer": "C",
              "explanation": "NGS enables multi-gene, multi-variant detection in parallel.",
              "difficulty": "medium"
            },
            {
              "stem": "A broad NGS panel is ordered for a lung adenocarcinoma. Compared with single\u2011gene Sanger Sequencing, what is the main advantage?",
              "options": {
                "A": "Cannot detect gene fusions",
                "B": "Direct measurement of protein phosphorylation states",
                "C": "Simultaneous detection of SNVs, indels, fusions, CNVs across many genes",
                "D": "Lower depth but faster than PCR"
              },
              "answer": "C",
              "explanation": "NGS enables multi-gene, multi-variant detection in parallel.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Next-Generation Sequencing (NGS)",
          "question_count": 2,
          "long_questions": [
            {
              "id": "L3_Q1",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 45-year-old woman with suspected BRCA1 mutation undergoes a genetic test that sequences all exons of her DNA. The method used relies on massively parallel sequencing of short DNA fragments. Which technique is most likely used?",
              "options": {
                "A": "Sanger sequencing",
                "B": "Next-generation sequencing",
                "C": "Southern blotting",
                "D": "PCR with RFLP",
                "E": "Northern blotting"
              },
              "answer": "B",
              "explanation": "Next-generation sequencing allows rapid, high-throughput sequencing of exons and genomes, unlike slower Sanger sequencing.",
              "image": null
            },
            {
              "id": "L3_Q18",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 6-year-old boy with suspected thalassemia undergoes sequencing of the HBB gene. The laboratory uses whole-exome sequencing. Which part of the genome is being targeted?",
              "options": {
                "A": "Entire genome",
                "B": "Intronic regions only",
                "C": "Exons (protein-coding regions)",
                "D": "Mitochondrial DNA",
                "E": "Promoter regions only"
              },
              "answer": "C",
              "explanation": "Whole-exome sequencing targets exons, which represent ~2% of the genome but contain most disease-causing mutations.",
              "image": null
            }
          ]
        },
        {
          "name": "Bisulfite Sequencing (Epigenetics)",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L3_Q13",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 25-year-old woman undergoes molecular testing for Fragile X syndrome. Sodium bisulfite is used to modify unmethylated cytosines to uracil. Which condition does this method specifically assess?",
              "options": {
                "A": "DNA methylation",
                "B": "Histone acetylation",
                "C": "DNA fragmentation",
                "D": "Chromosomal duplication",
                "E": "RNA splicing"
              },
              "answer": "A",
              "explanation": "Bisulfite sequencing detects methylated cytosines, useful for assessing epigenetic changes.",
              "image": null
            },
            {
              "stem": "A broad NGS panel is ordered for a lung adenocarcinoma. Compared with single\u2011gene Bisulfite Sequencing (Epigenetics), what is the main advantage?",
              "options": {
                "A": "Direct measurement of protein phosphorylation states",
                "B": "Lower depth but faster than PCR",
                "C": "Simultaneous detection of SNVs, indels, fusions, CNVs across many genes",
                "D": "Cannot detect gene fusions"
              },
              "answer": "C",
              "explanation": "NGS enables multi-gene, multi-variant detection in parallel.",
              "difficulty": "medium"
            },
            {
              "stem": "A broad NGS panel is ordered for a lung adenocarcinoma. Compared with single\u2011gene Bisulfite Sequencing (Epigenetics), what is the main advantage?",
              "options": {
                "A": "Direct measurement of protein phosphorylation states",
                "B": "Lower depth but faster than PCR",
                "C": "Simultaneous detection of SNVs, indels, fusions, CNVs across many genes",
                "D": "Cannot detect gene fusions"
              },
              "answer": "C",
              "explanation": "NGS enables multi-gene, multi-variant detection in parallel.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "VNTR and STR Analysis",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L3_Q6",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 60-year-old man with suspected colorectal carcinoma undergoes microsatellite instability testing. The test detects instability of short tandem repeats in tumor DNA compared with normal tissue DNA. Which syndrome is this most associated with?",
              "options": {
                "A": "FAP",
                "B": "Lynch syndrome",
                "C": "Cowden syndrome",
                "D": "Li-Fraumeni syndrome",
                "E": "Peutz-Jeghers syndrome"
              },
              "answer": "B",
              "explanation": "MSI testing identifies mismatch repair deficiency, characteristic of Lynch syndrome.",
              "image": null
            },
            {
              "id": "L3_Q16",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 33-year-old man undergoes PCR-based genotyping for short tandem repeats (STRs) as part of a forensic case. Which feature makes STRs particularly useful in this context?",
              "options": {
                "A": "High conservation across individuals",
                "B": "High variability in repeat number between individuals",
                "C": "Resistance to DNA degradation",
                "D": "Inability to amplify by PCR",
                "E": "Presence only in coding regions"
              },
              "answer": "B",
              "explanation": "STRs vary greatly in repeat number between individuals, making them ideal for forensic identification.",
              "image": null
            },
            {
              "id": "L3_Q17",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 48-year-old man with suspected colon cancer undergoes FISH testing for HER2 amplification. Which finding would confirm amplification?",
              "options": {
                "A": "No fluorescent signals",
                "B": "Equal HER2 and centromere signals",
                "C": "Excess HER2 signals compared to centromere",
                "D": "Excess centromere signals compared to HER2",
                "E": "Single HER2 signal"
              },
              "answer": "C",
              "explanation": "HER2 amplification is diagnosed when HER2 probe signals outnumber centromere signals.",
              "image": null
            }
          ]
        },
        {
          "name": "Restriction Endonucleases (Cutting DNA)",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Restriction Endonucleases (Cutting DNA) within the broader topic of Molecular Diagnostics. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Serum tumor markers alone establish diagnosis",
                "B": "Reliance on imaging alone",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Restriction Endonucleases (Cutting DNA), which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Patient age alone",
                "B": "Evidence of invasion and metastatic potential",
                "C": "Presence of inflammation",
                "D": "Lesion size alone"
              },
              "answer": "B",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Gel Electrophoresis",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Gel Electrophoresis within the broader topic of Molecular Diagnostics. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Integration of histology with molecular testing correlating with clinical context",
                "C": "Reliance on imaging alone",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "B",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Gel Electrophoresis, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Presence of inflammation",
                "B": "Lesion size alone",
                "C": "Patient age alone",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Molecular Cloning",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Molecular Cloning within the broader topic of Molecular Diagnostics. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Serum tumor markers alone establish diagnosis",
                "B": "Reliance on imaging alone",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Molecular Cloning, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Evidence of invasion and metastatic potential",
                "B": "Patient age alone",
                "C": "Lesion size alone",
                "D": "Presence of inflammation"
              },
              "answer": "A",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        }
      ]
    },
    {
      "topic": "Cytogenetics",
      "subtopics": [
        {
          "name": "What Cytogenetics Studies & Why It Matters",
          "question_count": 2,
          "long_questions": [
            {
              "id": "L4_Q13",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 29-year-old woman has a miscarriage at 12 weeks. Cytogenetics reveals triploidy (69,XXX). What is the most common mechanism?",
              "options": {
                "A": "Nondisjunction in meiosis I",
                "B": "Fertilization by two sperm",
                "C": "Maternal age >40",
                "D": "Robertsonian translocation",
                "E": "Isochromosome formation"
              },
              "answer": "B",
              "explanation": "Triploidy often results from dispermy (fertilization of one ovum by two sperm).",
              "image": null
            },
            {
              "id": "L4_Q15",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A cytogenetic study shows multiple double minute chromosomes in a sarcoma. Which phenomenon does this represent?",
              "options": {
                "A": "Translocation",
                "B": "Gene amplification",
                "C": "Deletion",
                "D": "Insertion",
                "E": "Ring chromosome"
              },
              "answer": "B",
              "explanation": "Double minutes are extrachromosomal DNA fragments indicating gene amplification (e.g., MYCN, MDM2).",
              "image": null
            }
          ]
        },
        {
          "name": "Aneuploidy & Trisomy: Epidemiology",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L4_Q5",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A newborn presents with micrognathia, webbed neck, lymphedema of hands/feet, and a wide chest. Karyotype reveals 45,X. Which complication is most likely in adolescence?",
              "options": {
                "A": "Ovarian failure with infertility",
                "B": "Polycystic ovarian syndrome",
                "C": "Excess estrogen leading to early puberty",
                "D": "Adrenal hyperplasia",
                "E": "Multiple neurofibromas"
              },
              "answer": "A",
              "explanation": "Turner syndrome (45,X) \u2192 streak ovaries, infertility, short stature, and risk of coarctation of the aorta.",
              "image": null
            },
            {
              "stem": "A neonate is evaluated for a suspected microdeletion syndrome. Which test is most appropriate in Aneuploidy & Trisomy: Epidemiology?",
              "options": {
                "A": "Gram stain",
                "B": "FISH using a locus\u2011specific probe",
                "C": "Urine dipstick",
                "D": "Direct Coombs test"
              },
              "answer": "B",
              "explanation": "FISH (or microarray) detects microdeletions below karyotype resolution.",
              "difficulty": "medium"
            },
            {
              "stem": "A neonate is evaluated for a suspected microdeletion syndrome. Which test is most appropriate in Aneuploidy & Trisomy: Epidemiology?",
              "options": {
                "A": "Gram stain",
                "B": "FISH using a locus\u2011specific probe",
                "C": "Urine dipstick",
                "D": "Direct Coombs test"
              },
              "answer": "B",
              "explanation": "FISH (or microarray) detects microdeletions below karyotype resolution.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Trisomy 21 (Down Syndrome)",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L4_Q1",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 2-day-old infant is noted to have hypotonia, a flat nasal bridge, upslanting palpebral fissures, a single palmar crease, and a systolic murmur. Karyotype shows 47,XX,+21. Which of the following complications is most likely to develop later in life?",
              "options": {
                "A": "Cleft lip and palate",
                "B": "Acute lymphoblastic leukemia",
                "C": "Polycystic kidney disease",
                "D": "Neurofibromas",
                "E": "Retinoblastoma"
              },
              "answer": "B",
              "explanation": "Down syndrome (trisomy 21) is associated with congenital heart disease, intellectual disability, early-onset Alzheimer-like changes, and increased risk of acute leukemias.",
              "image": null
            },
            {
              "id": "L4_Q6",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 17-year-old boy presents with tall stature, gynecomastia, small testes, and infertility. Karyotype shows 47,XXY. What syndrome does he have?",
              "options": {
                "A": "Down syndrome",
                "B": "Klinefelter syndrome",
                "C": "Edwards syndrome",
                "D": "Turner syndrome",
                "E": "XYY syndrome"
              },
              "answer": "B",
              "explanation": "Klinefelter syndrome (47,XXY) presents with tall stature, gynecomastia, small testes, infertility, and increased risk of breast cancer.",
              "image": null
            },
            {
              "id": "L4_Q14",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 14-year-old boy has tall stature, acne, and aggressive behavior. Karyotype shows 47,XYY. Which of the following is correct?",
              "options": {
                "A": "Always infertile",
                "B": "Associated with hypogonadism",
                "C": "Increased risk of learning difficulties and behavioral problems",
                "D": "Associated with congenital heart defects",
                "E": "Associated with renal failure"
              },
              "answer": "C",
              "explanation": "47,XYY males may be tall with acne and learning/behavioral difficulties, but are usually fertile.",
              "image": null
            }
          ]
        },
        {
          "name": "Trisomy 18 (Edwards Syndrome)",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L4_Q2",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A newborn girl is found to have clenched fists with overlapping fingers, rocker-bottom feet, and a ventricular septal defect. Karyotype shows 47,XX,+18. What is the most likely diagnosis?",
              "options": {
                "A": "Down syndrome",
                "B": "Edwards syndrome",
                "C": "Patau syndrome",
                "D": "Turner syndrome",
                "E": "Cri-du-chat syndrome"
              },
              "answer": "B",
              "explanation": "Edwards syndrome (trisomy 18) presents with clenched fists, rocker-bottom feet, congenital heart disease, and severe intellectual disability.",
              "image": null
            },
            {
              "stem": "A neonate is evaluated for a suspected microdeletion syndrome. Which test is most appropriate in Trisomy 18 (Edwards Syndrome)?",
              "options": {
                "A": "Direct Coombs test",
                "B": "FISH using a locus\u2011specific probe",
                "C": "Urine dipstick",
                "D": "Gram stain"
              },
              "answer": "B",
              "explanation": "FISH (or microarray) detects microdeletions below karyotype resolution.",
              "difficulty": "medium"
            },
            {
              "stem": "A neonate is evaluated for a suspected microdeletion syndrome. Which test is most appropriate in Trisomy 18 (Edwards Syndrome)?",
              "options": {
                "A": "Direct Coombs test",
                "B": "FISH using a locus\u2011specific probe",
                "C": "Urine dipstick",
                "D": "Gram stain"
              },
              "answer": "B",
              "explanation": "FISH (or microarray) detects microdeletions below karyotype resolution.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Trisomy 13 (Patau Syndrome)",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L4_Q3",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A neonate is noted to have severe growth retardation, microcephaly, cleft lip and palate, and congenital heart disease. Karyotype shows 47,XY,+13. Which condition is most likely?",
              "options": {
                "A": "Down syndrome",
                "B": "Edwards syndrome",
                "C": "Patau syndrome",
                "D": "Turner syndrome",
                "E": "Klinefelter syndrome"
              },
              "answer": "C",
              "explanation": "Patau syndrome (trisomy 13) causes severe developmental delay, midline defects like cleft lip/palate, congenital heart disease, and early death.",
              "image": null
            },
            {
              "stem": "A neonate is evaluated for a suspected microdeletion syndrome. Which test is most appropriate in Trisomy 13 (Patau Syndrome)?",
              "options": {
                "A": "Direct Coombs test",
                "B": "Urine dipstick",
                "C": "FISH using a locus\u2011specific probe",
                "D": "Gram stain"
              },
              "answer": "C",
              "explanation": "FISH (or microarray) detects microdeletions below karyotype resolution.",
              "difficulty": "medium"
            },
            {
              "stem": "A neonate is evaluated for a suspected microdeletion syndrome. Which test is most appropriate in Trisomy 13 (Patau Syndrome)?",
              "options": {
                "A": "Direct Coombs test",
                "B": "Urine dipstick",
                "C": "FISH using a locus\u2011specific probe",
                "D": "Gram stain"
              },
              "answer": "C",
              "explanation": "FISH (or microarray) detects microdeletions below karyotype resolution.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Robertsonian Translocations",
          "question_count": 2,
          "long_questions": [
            {
              "id": "L4_Q4",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 28-year-old woman presents with recurrent miscarriages. Her karyotype is 45,XX,rob(14;21). She is a balanced Robertsonian translocation carrier. Which is her most significant reproductive risk?",
              "options": {
                "A": "Turner syndrome offspring",
                "B": "Down syndrome offspring",
                "C": "Patau syndrome offspring",
                "D": "Triploidy",
                "E": "Cri-du-chat syndrome"
              },
              "answer": "B",
              "explanation": "Robertsonian translocation carriers involving chromosome 21 are at increased risk of having offspring with Down syndrome.",
              "image": null
            },
            {
              "id": "L4_Q18",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A patient with acute promyelocytic leukemia (APL) undergoes karyotype analysis. The abnormality is t(15;17). Which therapy specifically targets this translocation?",
              "options": {
                "A": "Imatinib",
                "B": "All-trans retinoic acid",
                "C": "Rituximab",
                "D": "Trastuzumab",
                "E": "Methotrexate"
              },
              "answer": "B",
              "explanation": "t(15;17) in APL produces PML-RARA fusion protein, treated with all-trans retinoic acid (ATRA).",
              "image": null
            }
          ]
        },
        {
          "name": "Isochromosomes & Ring Chromosomes",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L4_Q12",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A newborn presents with ambiguous genitalia and adrenal insufficiency. Chromosomal analysis shows 46,XY with an isochromosome formation. Which of the following describes this abnormality?",
              "options": {
                "A": "Loss of both chromosome arms",
                "B": "One arm lost, the other duplicated",
                "C": "Fusion of two acrocentric chromosomes",
                "D": "Gain of an extra chromosome",
                "E": "Mosaicism"
              },
              "answer": "B",
              "explanation": "Isochromosome = one arm lost, other duplicated. Results in unbalanced chromosomal content.",
              "image": null
            },
            {
              "stem": "A neonate is evaluated for a suspected microdeletion syndrome. Which test is most appropriate in Isochromosomes & Ring Chromosomes?",
              "options": {
                "A": "Urine dipstick",
                "B": "Gram stain",
                "C": "FISH using a locus\u2011specific probe",
                "D": "Direct Coombs test"
              },
              "answer": "C",
              "explanation": "FISH (or microarray) detects microdeletions below karyotype resolution.",
              "difficulty": "medium"
            },
            {
              "stem": "A neonate is evaluated for a suspected microdeletion syndrome. Which test is most appropriate in Isochromosomes & Ring Chromosomes?",
              "options": {
                "A": "Urine dipstick",
                "B": "Gram stain",
                "C": "FISH using a locus\u2011specific probe",
                "D": "Direct Coombs test"
              },
              "answer": "C",
              "explanation": "FISH (or microarray) detects microdeletions below karyotype resolution.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Classic Deletion & Microdeletion Syndromes",
          "question_count": 5,
          "long_questions": [
            {
              "id": "L4_Q7",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A neonate cries with a high-pitched cat-like cry and is noted to have microcephaly, hypertelorism, and severe intellectual disability. Karyotype reveals a deletion in 5p. Which syndrome is this?",
              "options": {
                "A": "Williams syndrome",
                "B": "Cri-du-chat syndrome",
                "C": "Angelman syndrome",
                "D": "Prader-Willi syndrome",
                "E": "DiGeorge syndrome"
              },
              "answer": "B",
              "explanation": "Cri-du-chat syndrome results from a deletion in chromosome 5p, characterized by cat-like cry and severe intellectual disability.",
              "image": null
            },
            {
              "id": "L4_Q8",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A newborn with congenital heart defects, hypocalcemia, and recurrent infections is diagnosed with DiGeorge syndrome. Which chromosomal abnormality is present?",
              "options": {
                "A": "Deletion 5p",
                "B": "Deletion 22q11",
                "C": "Deletion 15q11 paternal",
                "D": "Deletion 15q11 maternal",
                "E": "Trisomy 21"
              },
              "answer": "B",
              "explanation": "DiGeorge syndrome is caused by 22q11 deletion, leading to thymic aplasia, hypocalcemia, and cardiac outflow tract defects.",
              "image": null
            },
            {
              "id": "L4_Q9",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 6-year-old boy has severe obesity, hypotonia, hypogonadism, and intellectual disability. Genetic testing shows a paternal deletion of 15q11. What syndrome is this?",
              "options": {
                "A": "Angelman syndrome",
                "B": "Prader-Willi syndrome",
                "C": "Cri-du-chat syndrome",
                "D": "Edwards syndrome",
                "E": "Williams syndrome"
              },
              "answer": "B",
              "explanation": "Prader-Willi syndrome results from loss of paternal allele (15q11). Features include hypotonia, obesity, hypogonadism, and intellectual disability.",
              "image": null
            },
            {
              "id": "L4_Q10",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 6-year-old girl presents with seizures, inappropriate laughter, ataxia, and intellectual disability. Genetic testing shows a maternal deletion of 15q11. Which syndrome is this?",
              "options": {
                "A": "Prader-Willi syndrome",
                "B": "Angelman syndrome",
                "C": "Cri-du-chat syndrome",
                "D": "DiGeorge syndrome",
                "E": "Williams syndrome"
              },
              "answer": "B",
              "explanation": "Angelman syndrome results from loss of maternal allele (15q11). Features include seizures, ataxia, severe ID, and happy puppet laughter.",
              "image": null
            },
            {
              "id": "L4_Q11",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 4-year-old girl has elfin facies, friendly personality, supravalvular aortic stenosis, and intellectual disability. FISH testing reveals a deletion on chromosome 7q11. Which diagnosis is correct?",
              "options": {
                "A": "Williams syndrome",
                "B": "Cri-du-chat syndrome",
                "C": "Angelman syndrome",
                "D": "Prader-Willi syndrome",
                "E": "DiGeorge syndrome"
              },
              "answer": "A",
              "explanation": "Williams syndrome (7q11 deletion) \u2192 elfin facies, friendliness, cardiovascular disease, intellectual disability.",
              "image": null
            }
          ]
        },
        {
          "name": "Structural Rearrangements: inv, ins, t",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L4_Q16",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A newborn presents with partial trisomy due to an unbalanced translocation. Which of the following best describes this cytogenetic abnormality?",
              "options": {
                "A": "Loss of chromosomal arm",
                "B": "Gain of a segment due to translocation",
                "C": "Two copies of paternal allele",
                "D": "Deletion of maternal allele",
                "E": "Loss of centromere"
              },
              "answer": "B",
              "explanation": "Partial trisomy results from gain of a chromosome segment due to unbalanced translocation.",
              "image": null
            },
            {
              "stem": "A case is suspected to involve Structural Rearrangements: inv, ins, t within the broader topic of Cytogenetics. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Reliance on imaging alone",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "A case is suspected to involve Structural Rearrangements: inv, ins, t within the broader topic of Cytogenetics. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Reliance on imaging alone",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "FISH Probe Types & Applications",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L4_Q17",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A patient with suspected CML undergoes cytogenetic testing. Karyotype shows t(9;22). Which fusion gene is formed?",
              "options": {
                "A": "MYC-BCL2",
                "B": "BCR-ABL",
                "C": "EWS-FLI1",
                "D": "PML-RARA",
                "E": "ALK-EML4"
              },
              "answer": "B",
              "explanation": "The Philadelphia chromosome t(9;22) results in BCR-ABL fusion, causing constitutive tyrosine kinase activity in CML.",
              "image": null
            },
            {
              "stem": "A breast tumor is equivocal by IHC for HER2. In the context of FISH Probe Types & Applications, which test confirms gene amplification?",
              "options": {
                "A": "Southern blot of HER2",
                "B": "RT\u2011PCR for HER2 mRNA",
                "C": "FISH with HER2 probe and CEP17 control",
                "D": "Sanger sequencing of HER2 coding exons"
              },
              "answer": "C",
              "explanation": "FISH directly assesses gene amplification (often as HER2:CEP17 ratio).",
              "difficulty": "medium"
            },
            {
              "stem": "A breast tumor is equivocal by IHC for HER2. In the context of FISH Probe Types & Applications, which test confirms gene amplification?",
              "options": {
                "A": "Southern blot of HER2",
                "B": "RT\u2011PCR for HER2 mRNA",
                "C": "FISH with HER2 probe and CEP17 control",
                "D": "Sanger sequencing of HER2 coding exons"
              },
              "answer": "C",
              "explanation": "FISH directly assesses gene amplification (often as HER2:CEP17 ratio).",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Karyotyping: Sample Prep & G-Banding Workflow",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Karyotyping: Sample Prep & G-Banding Workflow within the broader topic of Cytogenetics. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Reliance on imaging alone",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Karyotyping: Sample Prep & G-Banding Workflow, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Evidence of invasion and metastatic potential",
                "B": "Presence of inflammation",
                "C": "Patient age alone",
                "D": "Lesion size alone"
              },
              "answer": "A",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "What Bands Mean & Resolution",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve What Bands Mean & Resolution within the broader topic of Cytogenetics. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Reliance on imaging alone",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Exclusion of biopsy to avoid tumor spread"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In What Bands Mean & Resolution, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Lesion size alone",
                "B": "Patient age alone",
                "C": "Evidence of invasion and metastatic potential",
                "D": "Presence of inflammation"
              },
              "answer": "C",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Chromosome Anatomy: Arms & Centromeres",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Chromosome Anatomy: Arms & Centromeres within the broader topic of Cytogenetics. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Reliance on imaging alone",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Chromosome Anatomy: Arms & Centromeres, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Patient age alone",
                "B": "Evidence of invasion and metastatic potential",
                "C": "Lesion size alone",
                "D": "Presence of inflammation"
              },
              "answer": "B",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "ISCN Nomenclature Essentials",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve ISCN Nomenclature Essentials within the broader topic of Cytogenetics. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Reliance on imaging alone"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In ISCN Nomenclature Essentials, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Presence of inflammation",
                "B": "Evidence of invasion and metastatic potential",
                "C": "Lesion size alone",
                "D": "Patient age alone"
              },
              "answer": "B",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Limits of Karyotyping",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Limits of Karyotyping within the broader topic of Cytogenetics. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Reliance on imaging alone",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Limits of Karyotyping, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Presence of inflammation",
                "B": "Evidence of invasion and metastatic potential",
                "C": "Patient age alone",
                "D": "Lesion size alone"
              },
              "answer": "B",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Mechanisms: Meiotic Nondisjunction (I vs II)",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Mechanisms: Meiotic Nondisjunction (I vs II) within the broader topic of Cytogenetics. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Integration of histology with molecular testing correlating with clinical context",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Exclusion of biopsy to avoid tumor spread"
              },
              "answer": "B",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Mechanisms: Meiotic Nondisjunction (I vs II), which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Presence of inflammation",
                "B": "Patient age alone",
                "C": "Lesion size alone",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Mosaicism",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A biopsy shows full\u2011thickness epithelial atypia with an intact basement membrane. This best describes Mosaicism. What is the correct classification?",
              "options": {
                "A": "Invasive carcinoma",
                "B": "Metaplasia",
                "C": "Carcinoma in situ",
                "D": "Hyperplasia without atypia"
              },
              "answer": "C",
              "explanation": "Full-thickness atypia without invasion is CIS.",
              "difficulty": "medium"
            },
            {
              "stem": "In Mosaicism, which transition represents true invasion?",
              "options": {
                "A": "Loss of polarity within epithelium",
                "B": "Increasing nuclear:cytoplasmic ratio",
                "C": "Higher mitotic rate",
                "D": "Breaching the basement membrane"
              },
              "answer": "D",
              "explanation": "Invasion is defined by basement membrane breach; other changes are intraepithelial.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Partial Trisomies/Duplications vs Deletions",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Partial Trisomies/Duplications vs Deletions within the broader topic of Cytogenetics. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Integration of histology with molecular testing correlating with clinical context",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Reliance on imaging alone"
              },
              "answer": "B",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Partial Trisomies/Duplications vs Deletions, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Lesion size alone",
                "B": "Evidence of invasion and metastatic potential",
                "C": "Patient age alone",
                "D": "Presence of inflammation"
              },
              "answer": "B",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "FISH: How It Works & When To Use",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A breast tumor is equivocal by IHC for HER2. In the context of FISH: How It Works & When To Use, which test confirms gene amplification?",
              "options": {
                "A": "RT\u2011PCR for HER2 mRNA",
                "B": "FISH with HER2 probe and CEP17 control",
                "C": "Sanger sequencing of HER2 coding exons",
                "D": "Southern blot of HER2"
              },
              "answer": "B",
              "explanation": "FISH directly assesses gene amplification (often as HER2:CEP17 ratio).",
              "difficulty": "medium"
            },
            {
              "stem": "For a suspected ALK rearrangement in lung cancer, which FISH: How It Works & When To Use approach best detects gene fusion?",
              "options": {
                "A": "qPCR for expression level",
                "B": "Karyotype at 400 band resolution",
                "C": "Break-apart FISH assay",
                "D": "Immunoassay for ALK protein only"
              },
              "answer": "C",
              "explanation": "Break\u2011apart FISH detects rearrangements independent of fusion partner; IHC can screen, NGS or FISH confirms.",
              "difficulty": "medium"
            }
          ]
        }
      ]
    },
    {
      "topic": "Introduction to Carcinogenesis",
      "subtopics": [
        {
          "name": "Carcinogens: Classes and Examples",
          "question_count": 18,
          "long_questions": [
            {
              "id": "L5_Q1",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 55-year-old man with a 40-pack-year smoking history presents with chronic cough and weight loss. Imaging shows a lung mass. Which carcinogen in cigarette smoke most directly contributes to the DNA mutations leading to lung cancer?",
              "options": {
                "A": "Nitrosamines",
                "B": "Polycyclic aromatic hydrocarbons",
                "C": "Alcohol",
                "D": "Aflatoxin B1",
                "E": "Radon"
              },
              "answer": "B",
              "explanation": "Polycyclic aromatic hydrocarbons in cigarette smoke are potent mutagens responsible for lung cancer development.",
              "image": null
            },
            {
              "id": "L5_Q2",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 45-year-old woman presents with a liver mass. She lives in a region with high exposure to Aspergillus-contaminated grains. Which genetic change is most likely in her tumor?",
              "options": {
                "A": "p53 mutation",
                "B": "Rb mutation",
                "C": "KRAS mutation",
                "D": "BCR-ABL fusion",
                "E": "RET mutation"
              },
              "answer": "A",
              "explanation": "Aflatoxin B1 exposure leads to hepatocellular carcinoma via p53 mutations.",
              "image": null
            },
            {
              "id": "L5_Q3",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 62-year-old man presents with hematuria. He has a history of occupational exposure to aniline dyes. Which cancer is he at risk for?",
              "options": {
                "A": "Hepatocellular carcinoma",
                "B": "Bladder carcinoma",
                "C": "Lung carcinoma",
                "D": "Leukemia",
                "E": "Skin carcinoma"
              },
              "answer": "B",
              "explanation": "Aniline dye exposure is strongly linked to transitional cell carcinoma of the bladder.",
              "image": null
            },
            {
              "id": "L5_Q4",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 30-year-old man from Japan presents with abdominal pain and weight loss. Endoscopy reveals a gastric mass. He reports eating large quantities of smoked fish and pickled vegetables. Which carcinogen is implicated?",
              "options": {
                "A": "Nitrosamines",
                "B": "Aflatoxin",
                "C": "Polycyclic hydrocarbons",
                "D": "Arsenic",
                "E": "Vinyl chloride"
              },
              "answer": "A",
              "explanation": "Nitrosamines from smoked foods are linked to gastric carcinoma, especially in Japan.",
              "image": null
            },
            {
              "id": "L5_Q5",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 50-year-old man with chronic arsenic exposure from contaminated well water presents with skin hyperpigmentation and multiple skin nodules. Which cancer is most strongly associated?",
              "options": {
                "A": "Basal cell carcinoma",
                "B": "Squamous cell carcinoma of skin",
                "C": "Kaposi sarcoma",
                "D": "Osteosarcoma",
                "E": "Thyroid carcinoma"
              },
              "answer": "B",
              "explanation": "Arsenic exposure predisposes to squamous cell carcinoma of skin and lung cancer.",
              "image": null
            },
            {
              "id": "L5_Q6",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 47-year-old man presents with jaundice and hepatomegaly. He has a long history of vinyl chloride exposure in a plastics factory. Which malignancy is he predisposed to?",
              "options": {
                "A": "Hepatocellular carcinoma",
                "B": "Angiosarcoma of the liver",
                "C": "Cholangiocarcinoma",
                "D": "Hepatic adenoma",
                "E": "Metastatic carcinoma"
              },
              "answer": "B",
              "explanation": "Vinyl chloride is associated with hepatic angiosarcoma, a rare vascular tumor.",
              "image": null
            },
            {
              "id": "L5_Q7",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 40-year-old uranium miner presents with progressive shortness of breath. Chest CT shows multiple pulmonary nodules. Which carcinogen is most strongly implicated?",
              "options": {
                "A": "Benzene",
                "B": "Radon",
                "C": "Vinyl chloride",
                "D": "Asbestos",
                "E": "Polycyclic hydrocarbons"
              },
              "answer": "B",
              "explanation": "Radon exposure from uranium mining increases risk of lung cancer.",
              "image": null
            },
            {
              "id": "L5_Q8",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 70-year-old construction worker with a history of asbestos exposure presents with dyspnea. Imaging reveals diffuse pleural thickening. Which cancer is most likely?",
              "options": {
                "A": "Squamous cell carcinoma",
                "B": "Small cell carcinoma",
                "C": "Mesothelioma",
                "D": "Adenocarcinoma",
                "E": "Large cell carcinoma"
              },
              "answer": "C",
              "explanation": "Asbestos exposure is strongly linked to malignant mesothelioma of pleura.",
              "image": null
            },
            {
              "id": "L5_Q9",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 62-year-old man with chronic benzene exposure at work presents with pancytopenia. Bone marrow biopsy reveals blasts. Which malignancy is he at risk for?",
              "options": {
                "A": "CML",
                "B": "AML",
                "C": "CLL",
                "D": "Polycythemia vera",
                "E": "Hairy cell leukemia"
              },
              "answer": "B",
              "explanation": "Benzene exposure is linked to acute myeloid leukemia due to bone marrow toxicity.",
              "image": null
            },
            {
              "id": "L5_Q11",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 50-year-old farmer presents with hepatomegaly. He reports chronic consumption of foods contaminated with Aspergillus flavus. Which mutation is most likely in his hepatocellular carcinoma?",
              "options": {
                "A": "Rb loss",
                "B": "p53 mutation",
                "C": "KRAS mutation",
                "D": "EGFR mutation",
                "E": "APC mutation"
              },
              "answer": "B",
              "explanation": "Aflatoxin B1 exposure leads to characteristic p53 mutations in hepatocellular carcinoma.",
              "image": null
            },
            {
              "id": "L5_Q12",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 45-year-old man who has smoked for 20 years presents with hematuria. Cystoscopy shows a bladder mass. Exposure to which compound in cigarettes most likely caused this?",
              "options": {
                "A": "Arsenic",
                "B": "Nitrosamines",
                "C": "Naphthylamine",
                "D": "Aflatoxin",
                "E": "Vinyl chloride"
              },
              "answer": "C",
              "explanation": "\u03b2-naphthylamine, found in cigarette smoke, is linked to urothelial carcinoma.",
              "image": null
            },
            {
              "id": "L5_Q13",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 52-year-old woman presents with a breast mass. She has never smoked or used alcohol but has received multiple cycles of chemotherapy in the past. Which secondary malignancy is she at risk for?",
              "options": {
                "A": "Acute myeloid leukemia",
                "B": "Renal cell carcinoma",
                "C": "Colon adenocarcinoma",
                "D": "Thyroid carcinoma",
                "E": "Ovarian carcinoma"
              },
              "answer": "A",
              "explanation": "Chemotherapy agents, especially alkylating agents, predispose to therapy-related AML.",
              "image": null
            },
            {
              "id": "L5_Q14",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 61-year-old man presents with dysphagia and weight loss. He has a history of smoking and alcohol use. Esophageal biopsy reveals squamous cell carcinoma. Which synergistic effect contributed to his cancer risk?",
              "options": {
                "A": "Alcohol + nitrosamines",
                "B": "Smoking + alcohol",
                "C": "Smoking + aflatoxin",
                "D": "Alcohol + arsenic",
                "E": "Vinyl chloride + alcohol"
              },
              "answer": "B",
              "explanation": "Alcohol and smoking synergistically increase risk of squamous cell carcinoma of the esophagus.",
              "image": null
            },
            {
              "id": "L5_Q15",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 30-year-old woman presents with a cervical lesion. Biopsy shows dysplastic squamous epithelium with koilocytosis. Which viral infection is responsible?",
              "options": {
                "A": "EBV",
                "B": "HPV 16/18",
                "C": "HBV",
                "D": "HTLV-1",
                "E": "HCV"
              },
              "answer": "B",
              "explanation": "HPV 16/18 cause cervical cancer through E6 and E7 proteins, which inactivate p53 and Rb.",
              "image": null
            },
            {
              "id": "L5_Q16",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 48-year-old man from China presents with a nasopharyngeal mass. Biopsy shows poorly differentiated carcinoma with lymphoid stroma. Which viral infection is most likely responsible?",
              "options": {
                "A": "EBV",
                "B": "HPV",
                "C": "HBV",
                "D": "HTLV-1",
                "E": "HCV"
              },
              "answer": "A",
              "explanation": "EBV is linked to nasopharyngeal carcinoma, especially in southern China.",
              "image": null
            },
            {
              "id": "L5_Q17",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 55-year-old man with hepatocellular carcinoma is positive for HBsAg. Which viral protein is implicated in oncogenesis?",
              "options": {
                "A": "HBsAg",
                "B": "HBx protein",
                "C": "E6 protein",
                "D": "LMP-1 protein",
                "E": "Tax protein"
              },
              "answer": "B",
              "explanation": "HBV promotes oncogenesis through HBx protein, which interferes with p53 and enhances growth.",
              "image": null
            },
            {
              "id": "L5_Q18",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 44-year-old woman presents with a T-cell leukemia/lymphoma. Which virus is implicated?",
              "options": {
                "A": "EBV",
                "B": "HTLV-1",
                "C": "HCV",
                "D": "HPV",
                "E": "HIV"
              },
              "answer": "B",
              "explanation": "HTLV-1 is linked to adult T-cell leukemia/lymphoma in endemic regions (Japan, Caribbean).",
              "image": null
            },
            {
              "id": "L5_Q19",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 48-year-old man presents with fever, night sweats, and cervical lymphadenopathy. Biopsy shows Reed-Sternberg cells. Which infectious agent is most associated?",
              "options": {
                "A": "EBV",
                "B": "HTLV-1",
                "C": "HCV",
                "D": "HIV",
                "E": "HPV"
              },
              "answer": "A",
              "explanation": "EBV is associated with Hodgkin lymphoma (especially mixed cellularity type).",
              "image": null
            }
          ]
        },
        {
          "name": "Dose-Response and Threshold Effects",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L5_Q10",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 40-year-old woman presents with a thyroid nodule. She has a history of childhood radiation therapy for acne. Which type of thyroid cancer is she at increased risk for?",
              "options": {
                "A": "Papillary thyroid carcinoma",
                "B": "Medullary thyroid carcinoma",
                "C": "Anaplastic thyroid carcinoma",
                "D": "Follicular thyroid carcinoma",
                "E": "Hurthle cell adenoma"
              },
              "answer": "A",
              "explanation": "Radiation exposure increases risk of papillary thyroid carcinoma, which shows Orphan Annie nuclei and psammoma bodies.",
              "image": null
            },
            {
              "stem": "A case is suspected to involve Dose-Response and Threshold Effects within the broader topic of Introduction to Carcinogenesis. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Integration of histology with molecular testing correlating with clinical context",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Reliance on imaging alone"
              },
              "answer": "B",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "A case is suspected to involve Dose-Response and Threshold Effects within the broader topic of Introduction to Carcinogenesis. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Integration of histology with molecular testing correlating with clinical context",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Reliance on imaging alone"
              },
              "answer": "B",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Definition and Multistep Nature",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Definition and Multistep Nature within the broader topic of Introduction to Carcinogenesis. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Serum tumor markers alone establish diagnosis",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Reliance on imaging alone"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Definition and Multistep Nature, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Patient age alone",
                "B": "Lesion size alone",
                "C": "Presence of inflammation",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Most Common vs Most Deadly Cancers",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Most Common vs Most Deadly Cancers within the broader topic of Introduction to Carcinogenesis. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Reliance on imaging alone"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Most Common vs Most Deadly Cancers, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Lesion size alone",
                "B": "Presence of inflammation",
                "C": "Evidence of invasion and metastatic potential",
                "D": "Patient age alone"
              },
              "answer": "C",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Initiators vs Promoters",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Initiators vs Promoters within the broader topic of Introduction to Carcinogenesis. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Initiators vs Promoters, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Patient age alone",
                "B": "Evidence of invasion and metastatic potential",
                "C": "Presence of inflammation",
                "D": "Lesion size alone"
              },
              "answer": "B",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Latency and Field Cancerization",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Latency and Field Cancerization within the broader topic of Introduction to Carcinogenesis. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Reliance on imaging alone"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Latency and Field Cancerization, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Patient age alone",
                "B": "Evidence of invasion and metastatic potential",
                "C": "Presence of inflammation",
                "D": "Lesion size alone"
              },
              "answer": "B",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "DNA Repair Defects and Carcinogenesis",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A worker with long\u2011term DNA Repair Defects and Carcinogenesis exposure presents with liver lesions. Which malignancy is most associated?",
              "options": {
                "A": "Angiosarcoma of the liver",
                "B": "Renal cell carcinoma",
                "C": "Mesothelioma",
                "D": "Hepatocellular carcinoma from HBV"
              },
              "answer": "A",
              "explanation": "Vinyl chloride is linked to hepatic angiosarcoma; asbestos to mesothelioma.",
              "difficulty": "medium"
            },
            {
              "stem": "Which statement about DNA Repair Defects and Carcinogenesis is most accurate?",
              "options": {
                "A": "Only viral carcinogens act as initiators",
                "B": "Promoters are always mutagenic",
                "C": "Initiators cause DNA damage; promoters stimulate clonal expansion",
                "D": "Promoters cause DNA adducts; initiators act via hormones"
              },
              "answer": "C",
              "explanation": "Initiators create DNA damage; promoters are non-mutagenic factors that favor growth of initiated cells.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Epigenetics in Carcinogenesis",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A worker with long\u2011term Epigenetics in Carcinogenesis exposure presents with liver lesions. Which malignancy is most associated?",
              "options": {
                "A": "Angiosarcoma of the liver",
                "B": "Mesothelioma",
                "C": "Hepatocellular carcinoma from HBV",
                "D": "Renal cell carcinoma"
              },
              "answer": "A",
              "explanation": "Vinyl chloride is linked to hepatic angiosarcoma; asbestos to mesothelioma.",
              "difficulty": "medium"
            },
            {
              "stem": "Which statement about Epigenetics in Carcinogenesis is most accurate?",
              "options": {
                "A": "Promoters are always mutagenic",
                "B": "Initiators cause DNA damage; promoters stimulate clonal expansion",
                "C": "Only viral carcinogens act as initiators",
                "D": "Promoters cause DNA adducts; initiators act via hormones"
              },
              "answer": "B",
              "explanation": "Initiators create DNA damage; promoters are non-mutagenic factors that favor growth of initiated cells.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Hallmarks of Cancer",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Hallmarks of Cancer within the broader topic of Introduction to Carcinogenesis. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Reliance on imaging alone",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Hallmarks of Cancer, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Lesion size alone",
                "B": "Patient age alone",
                "C": "Presence of inflammation",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        }
      ]
    },
    {
      "topic": "Nucleotide Metabolism",
      "subtopics": [
        {
          "name": "PRPP Synthetase and Regulation",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L6_Q7",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 16-year-old boy presents with nephrolithiasis and gout. Genetic studies reveal an activating mutation in PRPP synthetase. Which pathway is most stimulated?",
              "options": {
                "A": "Purine synthesis",
                "B": "Pyrimidine synthesis",
                "C": "Pentose phosphate pathway",
                "D": "Urea cycle",
                "E": "Fatty acid oxidation"
              },
              "answer": "A",
              "explanation": "PRPP synthetase activation drives increased purine synthesis, leading to hyperuricemia and gout.",
              "image": null
            },
            {
              "stem": "A case is suspected to involve PRPP Synthetase and Regulation within the broader topic of Nucleotide Metabolism. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Reliance on imaging alone",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "A case is suspected to involve PRPP Synthetase and Regulation within the broader topic of Nucleotide Metabolism. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Reliance on imaging alone",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Key Enzyme: Glutamine-PRPP Amidotransferase",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L6_Q5",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 40-year-old man undergoing chemotherapy is treated with 5-fluorouracil. Which enzyme is most directly inhibited?",
              "options": {
                "A": "Thymidylate synthase",
                "B": "Dihydrofolate reductase",
                "C": "Ribonucleotide reductase",
                "D": "PRPP amidotransferase",
                "E": "HGPRT"
              },
              "answer": "A",
              "explanation": "5-FU inhibits thymidylate synthase, reducing dTMP synthesis and impairing DNA replication.",
              "image": null
            },
            {
              "stem": "A case is suspected to involve Key Enzyme: Glutamine-PRPP Amidotransferase within the broader topic of Nucleotide Metabolism. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Reliance on imaging alone"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "A case is suspected to involve Key Enzyme: Glutamine-PRPP Amidotransferase within the broader topic of Nucleotide Metabolism. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Reliance on imaging alone"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Lesch-Nyhan Syndrome (HGPRT Deficiency)",
          "question_count": 2,
          "long_questions": [
            {
              "id": "L6_Q1",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 5-year-old boy presents with self-mutilating behavior, gout, and choreoathetosis. Genetic analysis reveals a deficiency of hypoxanthine-guanine phosphoribosyltransferase (HGPRT). Which metabolite is most elevated in this condition?",
              "options": {
                "A": "Xanthine",
                "B": "Uric acid",
                "C": "Orotic acid",
                "D": "Cytidine",
                "E": "Thymidine"
              },
              "answer": "B",
              "explanation": "HGPRT deficiency (Lesch-Nyhan syndrome) leads to purine salvage failure, increased PRPP, overproduction of uric acid, and neurologic dysfunction.",
              "image": null
            },
            {
              "id": "L6_Q15",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 10-year-old boy presents with gout and severe neurobehavioral problems. Which inheritance pattern is seen in his condition?",
              "options": {
                "A": "Autosomal recessive",
                "B": "Autosomal dominant",
                "C": "X-linked recessive",
                "D": "Mitochondrial",
                "E": "X-linked dominant"
              },
              "answer": "C",
              "explanation": "Lesch-Nyhan syndrome (HGPRT deficiency) is X-linked recessive.",
              "image": null
            }
          ]
        },
        {
          "name": "Adenosine Deaminase (ADA) Deficiency",
          "question_count": 2,
          "long_questions": [
            {
              "id": "L6_Q2",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 2-year-old boy presents with recurrent infections, failure to thrive, and severe lymphopenia. Genetic testing shows a deficiency in adenosine deaminase (ADA). What is the consequence of this defect?",
              "options": {
                "A": "Excess dGTP inhibits ribonucleotide reductase",
                "B": "Excess uric acid deposition",
                "C": "Increased pyrimidine synthesis",
                "D": "Increased thymidine salvage",
                "E": "Increased AMP synthesis"
              },
              "answer": "A",
              "explanation": "ADA deficiency \u2192 accumulation of dATP, which inhibits ribonucleotide reductase, blocking DNA synthesis \u2192 severe combined immunodeficiency (SCID).",
              "image": null
            },
            {
              "id": "L6_Q10",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 28-year-old man presents with recurrent infections. Genetic testing shows a deficiency in ribonucleotide reductase. Which process is impaired?",
              "options": {
                "A": "Conversion of NDPs to dNDPs",
                "B": "Conversion of dUMP to dTMP",
                "C": "Conversion of IMP to GMP",
                "D": "Conversion of GMP to uric acid",
                "E": "Conversion of PRPP to IMP"
              },
              "answer": "A",
              "explanation": "Ribonucleotide reductase converts ribonucleotides (NDPs) to deoxyribonucleotides (dNDPs) for DNA synthesis.",
              "image": null
            }
          ]
        },
        {
          "name": "Purine Metabolism Drugs: Xanthine Oxidase Inhibitors",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L6_Q4",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 55-year-old man presents with severe joint pain and swelling in his big toe. Microscopy of joint fluid shows negatively birefringent needle-shaped crystals. Which enzyme is targeted by first-line therapy?",
              "options": {
                "A": "Xanthine oxidase",
                "B": "HGPRT",
                "C": "Adenosine deaminase",
                "D": "Dihydrofolate reductase",
                "E": "PRPP synthetase"
              },
              "answer": "A",
              "explanation": "Allopurinol inhibits xanthine oxidase, lowering uric acid levels in gout.",
              "image": null
            },
            {
              "id": "L6_Q13",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 45-year-old man with chronic gout is started on allopurinol. Which drug should be used with caution due to increased toxicity when combined with allopurinol?",
              "options": {
                "A": "5-FU",
                "B": "6-MP",
                "C": "Methotrexate",
                "D": "Cytarabine",
                "E": "Leucovorin"
              },
              "answer": "B",
              "explanation": "Allopurinol inhibits xanthine oxidase, which metabolizes 6-MP. Co-administration increases toxicity.",
              "image": null
            },
            {
              "id": "L6_Q19",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 34-year-old man presents with nephrolithiasis due to uric acid stones. Which drug reduces uric acid production by inhibiting xanthine oxidase?",
              "options": {
                "A": "Allopurinol",
                "B": "Colchicine",
                "C": "Probenecid",
                "D": "Sulfinpyrazone",
                "E": "Febuxostat"
              },
              "answer": "E",
              "explanation": "Febuxostat, like allopurinol, inhibits xanthine oxidase and reduces uric acid production.",
              "image": null
            }
          ]
        },
        {
          "name": "Pyrimidine De Novo Pathway",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L6_Q16",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 48-year-old man undergoing chemotherapy for colon cancer is treated with 5-FU. Which metabolite is directly depleted by this drug?",
              "options": {
                "A": "dUMP",
                "B": "dTMP",
                "C": "IMP",
                "D": "GMP",
                "E": "AMP"
              },
              "answer": "B",
              "explanation": "5-FU inhibits thymidylate synthase, depleting dTMP.",
              "image": null
            },
            {
              "stem": "A case is suspected to involve Pyrimidine De Novo Pathway within the broader topic of Nucleotide Metabolism. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Reliance on imaging alone"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "A case is suspected to involve Pyrimidine De Novo Pathway within the broader topic of Nucleotide Metabolism. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Reliance on imaging alone"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Orotic Aciduria: Type I and II",
          "question_count": 2,
          "long_questions": [
            {
              "id": "L6_Q3",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 7-year-old boy presents with developmental delay, megaloblastic anemia, and elevated orotic acid levels in urine. Which enzyme deficiency is most likely?",
              "options": {
                "A": "Ornithine transcarbamylase",
                "B": "UMP synthase",
                "C": "HGPRT",
                "D": "Adenosine deaminase",
                "E": "Glucose-6-phosphatase"
              },
              "answer": "B",
              "explanation": "Hereditary orotic aciduria results from UMP synthase deficiency, causing impaired pyrimidine synthesis and megaloblastic anemia unresponsive to B12/folate.",
              "image": null
            },
            {
              "id": "L6_Q11",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 7-year-old boy with developmental delay is found to have orotic aciduria. Which supplement would improve his symptoms?",
              "options": {
                "A": "Uridine",
                "B": "Folate",
                "C": "Vitamin B12",
                "D": "Allopurinol",
                "E": "Leucovorin"
              },
              "answer": "A",
              "explanation": "Uridine supplementation bypasses UMP synthase deficiency, correcting pyrimidine synthesis and anemia.",
              "image": null
            }
          ]
        },
        {
          "name": "Ribonucleotide Reductase",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L6_Q17",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 57-year-old man is treated with hydroxyurea for sickle cell disease. What is the mechanism of hydroxyurea in DNA synthesis?",
              "options": {
                "A": "Inhibits ribonucleotide reductase",
                "B": "Inhibits thymidylate synthase",
                "C": "Inhibits xanthine oxidase",
                "D": "Inhibits PRPP synthetase",
                "E": "Inhibits ADA"
              },
              "answer": "A",
              "explanation": "Hydroxyurea inhibits ribonucleotide reductase, blocking DNA synthesis and increasing HbF in sickle cell disease.",
              "image": null
            },
            {
              "stem": "A case is suspected to involve Ribonucleotide Reductase within the broader topic of Nucleotide Metabolism. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Reliance on imaging alone",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "A case is suspected to involve Ribonucleotide Reductase within the broader topic of Nucleotide Metabolism. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Reliance on imaging alone",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "dTMP Synthesis and Drug Targets",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L6_Q9",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 34-year-old man with colon cancer is given leucovorin (folinic acid) as part of his chemotherapy regimen. Which drug is most likely combined with leucovorin to enhance its effect?",
              "options": {
                "A": "5-FU",
                "B": "Methotrexate",
                "C": "Allopurinol",
                "D": "6-MP",
                "E": "Cytarabine"
              },
              "answer": "A",
              "explanation": "Leucovorin enhances binding of 5-FU to thymidylate synthase, increasing its efficacy.",
              "image": null
            },
            {
              "stem": "A case is suspected to involve dTMP Synthesis and Drug Targets within the broader topic of Nucleotide Metabolism. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Serum tumor markers alone establish diagnosis",
                "B": "Reliance on imaging alone",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Exclusion of biopsy to avoid tumor spread"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "A case is suspected to involve dTMP Synthesis and Drug Targets within the broader topic of Nucleotide Metabolism. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Serum tumor markers alone establish diagnosis",
                "B": "Reliance on imaging alone",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Exclusion of biopsy to avoid tumor spread"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Purine Analog Drugs",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L6_Q8",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 30-year-old man treated for acute lymphoblastic leukemia receives 6-mercaptopurine. Which enzyme is responsible for its activation?",
              "options": {
                "A": "HGPRT",
                "B": "Xanthine oxidase",
                "C": "PRPP synthetase",
                "D": "Thymidylate synthase",
                "E": "Adenosine deaminase"
              },
              "answer": "A",
              "explanation": "6-MP is activated by HGPRT to thio-IMP, which inhibits purine synthesis.",
              "image": null
            },
            {
              "stem": "A case is suspected to involve Purine Analog Drugs within the broader topic of Nucleotide Metabolism. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Reliance on imaging alone",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "A case is suspected to involve Purine Analog Drugs within the broader topic of Nucleotide Metabolism. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Reliance on imaging alone",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Pyrimidine Analog Drugs",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L6_Q14",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 40-year-old man undergoing chemotherapy develops hand-foot syndrome. He is receiving a drug that inhibits thymidylate synthase. Which drug is most likely?",
              "options": {
                "A": "Methotrexate",
                "B": "5-FU",
                "C": "Cytarabine",
                "D": "6-MP",
                "E": "Gemcitabine"
              },
              "answer": "B",
              "explanation": "5-FU inhibits thymidylate synthase and can cause hand-foot syndrome as a toxicity.",
              "image": null
            },
            {
              "stem": "A case is suspected to involve Pyrimidine Analog Drugs within the broader topic of Nucleotide Metabolism. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Integration of histology with molecular testing correlating with clinical context",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Reliance on imaging alone"
              },
              "answer": "B",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "A case is suspected to involve Pyrimidine Analog Drugs within the broader topic of Nucleotide Metabolism. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Integration of histology with molecular testing correlating with clinical context",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Reliance on imaging alone"
              },
              "answer": "B",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Antifolate Drugs",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L6_Q6",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 45-year-old woman treated for rheumatoid arthritis develops pancytopenia. She has been on methotrexate therapy. Which metabolite accumulates as a result of methotrexate\u2019s mechanism?",
              "options": {
                "A": "DHF",
                "B": "THF",
                "C": "IMP",
                "D": "Orotic acid",
                "E": "Xanthine"
              },
              "answer": "A",
              "explanation": "Methotrexate inhibits dihydrofolate reductase, leading to accumulation of DHF and impaired nucleotide synthesis.",
              "image": null
            },
            {
              "id": "L6_Q12",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 60-year-old man develops severe mucositis after chemotherapy. Which drug most likely caused this by inhibiting DNA synthesis via dihydrofolate reductase inhibition?",
              "options": {
                "A": "Methotrexate",
                "B": "5-FU",
                "C": "Cytarabine",
                "D": "6-MP",
                "E": "Cyclophosphamide"
              },
              "answer": "A",
              "explanation": "Methotrexate inhibits DHFR, blocking THF regeneration and nucleotide synthesis.",
              "image": null
            },
            {
              "id": "L6_Q18",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 63-year-old man develops megaloblastic anemia while on methotrexate therapy. Which rescue agent should be given to prevent this complication?",
              "options": {
                "A": "Uridine",
                "B": "Folinic acid (leucovorin)",
                "C": "Cytarabine",
                "D": "Allopurinol",
                "E": "Adenosine"
              },
              "answer": "B",
              "explanation": "Leucovorin (folinic acid) rescues cells from methotrexate toxicity by bypassing DHFR blockade.",
              "image": null
            }
          ]
        },
        {
          "name": "Overview of Nucleotide Pathways",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Overview of Nucleotide Pathways within the broader topic of Nucleotide Metabolism. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Overview of Nucleotide Pathways, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Patient age alone",
                "B": "Presence of inflammation",
                "C": "Evidence of invasion and metastatic potential",
                "D": "Lesion size alone"
              },
              "answer": "C",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Stepwise Donors in Purine Ring",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Stepwise Donors in Purine Ring within the broader topic of Nucleotide Metabolism. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Integration of histology with molecular testing correlating with clinical context",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Exclusion of biopsy to avoid tumor spread"
              },
              "answer": "B",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Stepwise Donors in Purine Ring, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Evidence of invasion and metastatic potential",
                "B": "Presence of inflammation",
                "C": "Lesion size alone",
                "D": "Patient age alone"
              },
              "answer": "A",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Branching to AMP vs GMP",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Branching to AMP vs GMP within the broader topic of Nucleotide Metabolism. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Reliance on imaging alone",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Branching to AMP vs GMP, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Patient age alone",
                "B": "Evidence of invasion and metastatic potential",
                "C": "Lesion size alone",
                "D": "Presence of inflammation"
              },
              "answer": "B",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Purine Salvage Pathway",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Purine Salvage Pathway within the broader topic of Nucleotide Metabolism. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Integration of histology with molecular testing correlating with clinical context",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Reliance on imaging alone"
              },
              "answer": "B",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Purine Salvage Pathway, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Evidence of invasion and metastatic potential",
                "B": "Presence of inflammation",
                "C": "Patient age alone",
                "D": "Lesion size alone"
              },
              "answer": "A",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Kelley-Seegmiller Syndrome",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Kelley-Seegmiller Syndrome within the broader topic of Nucleotide Metabolism. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Reliance on imaging alone",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Kelley-Seegmiller Syndrome, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Patient age alone",
                "B": "Evidence of invasion and metastatic potential",
                "C": "Presence of inflammation",
                "D": "Lesion size alone"
              },
              "answer": "B",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Xanthinuria",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Xanthinuria within the broader topic of Nucleotide Metabolism. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Xanthinuria, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Patient age alone",
                "B": "Evidence of invasion and metastatic potential",
                "C": "Lesion size alone",
                "D": "Presence of inflammation"
              },
              "answer": "B",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Purine Degradation Overview",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Purine Degradation Overview within the broader topic of Nucleotide Metabolism. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Reliance on imaging alone"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Purine Degradation Overview, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Evidence of invasion and metastatic potential",
                "B": "Patient age alone",
                "C": "Lesion size alone",
                "D": "Presence of inflammation"
              },
              "answer": "A",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Leflunomide Mechanism",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Leflunomide Mechanism within the broader topic of Nucleotide Metabolism. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Serum tumor markers alone establish diagnosis",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Reliance on imaging alone",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Leflunomide Mechanism, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Lesion size alone",
                "B": "Evidence of invasion and metastatic potential",
                "C": "Patient age alone",
                "D": "Presence of inflammation"
              },
              "answer": "B",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Dihydropyrimidine Dehydrogenase (DPD) Deficiency",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Dihydropyrimidine Dehydrogenase (DPD) Deficiency within the broader topic of Nucleotide Metabolism. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Reliance on imaging alone",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Dihydropyrimidine Dehydrogenase (DPD) Deficiency, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Lesion size alone",
                "B": "Patient age alone",
                "C": "Presence of inflammation",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Clinical Integration: Tumor Lysis Syndrome",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Clinical Integration: Tumor Lysis Syndrome within the broader topic of Nucleotide Metabolism. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Exclusion of biopsy to avoid tumor spread"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Clinical Integration: Tumor Lysis Syndrome, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Patient age alone",
                "B": "Presence of inflammation",
                "C": "Lesion size alone",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        }
      ]
    },
    {
      "topic": "Cytogenetics of Cancer",
      "subtopics": [
        {
          "name": "Multidrug Resistance and BCL2 Overexpression",
          "question_count": 4,
          "long_questions": [
            {
              "id": "L7_Q4",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 28-year-old man presents with painless lymphadenopathy. Cytogenetics shows t(8;14). Which protein is dysregulated?",
              "options": {
                "A": "BCL2",
                "B": "MYC",
                "C": "BCR-ABL",
                "D": "p53",
                "E": "RB"
              },
              "answer": "B",
              "explanation": "Burkitt lymphoma is caused by t(8;14), leading to MYC overexpression and rapid cell proliferation.",
              "image": null
            },
            {
              "id": "L7_Q7",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 40-year-old woman with follicular lymphoma is found to have a t(14;18) translocation. Which protein is overexpressed?",
              "options": {
                "A": "BCL2",
                "B": "MYC",
                "C": "p53",
                "D": "Rb",
                "E": "Cyclin D1"
              },
              "answer": "A",
              "explanation": "t(14;18) leads to BCL2 overexpression, inhibiting apoptosis in follicular lymphoma.",
              "image": null
            },
            {
              "id": "L7_Q8",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 55-year-old man with mantle cell lymphoma is found to have t(11;14). Which protein is overexpressed?",
              "options": {
                "A": "Cyclin D1",
                "B": "BCL2",
                "C": "MYC",
                "D": "p53",
                "E": "APC"
              },
              "answer": "A",
              "explanation": "t(11;14) translocation causes cyclin D1 overexpression, driving G1/S progression in mantle cell lymphoma.",
              "image": null
            },
            {
              "id": "L7_Q19",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 65-year-old man with non-Hodgkin lymphoma is found to have a t(8;14) translocation. Which immunoglobulin locus is involved?",
              "options": {
                "A": "IgM",
                "B": "IgG",
                "C": "IgA",
                "D": "IgE",
                "E": "Ig heavy chain"
              },
              "answer": "E",
              "explanation": "In Burkitt lymphoma, MYC is translocated to the Ig heavy chain locus on chromosome 14.",
              "image": null
            }
          ]
        },
        {
          "name": "BCL2 Translocation t(14;18)",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L7_Q16",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 14-year-old boy with Burkitt lymphoma presents with jaw mass. Which viral infection is most strongly associated with his cytogenetic abnormality?",
              "options": {
                "A": "HCV",
                "B": "HBV",
                "C": "EBV",
                "D": "HIV",
                "E": "HPV"
              },
              "answer": "C",
              "explanation": "EBV is strongly associated with endemic Burkitt lymphoma (t(8;14), MYC activation).",
              "image": null
            },
            {
              "stem": "A case is suspected to involve BCL2 Translocation t(14;18) within the broader topic of Cytogenetics of Cancer. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "A case is suspected to involve BCL2 Translocation t(14;18) within the broader topic of Cytogenetics of Cancer. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Philadelphia Chromosome and BCR-ABL Fusion",
          "question_count": 7,
          "long_questions": [
            {
              "id": "L7_Q1",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 45-year-old man presents with splenomegaly and leukocytosis. Cytogenetic analysis reveals a t(9;22) translocation. Which abnormal fusion protein drives this malignancy?",
              "options": {
                "A": "PML-RARA",
                "B": "BCR-ABL",
                "C": "EWS-FLI1",
                "D": "MYC-IGH",
                "E": "ALK-EML4"
              },
              "answer": "B",
              "explanation": "The Philadelphia chromosome t(9;22) produces the BCR-ABL fusion gene, a constitutively active tyrosine kinase driving CML.",
              "image": null
            },
            {
              "id": "L7_Q2",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 36-year-old man presents with gingival bleeding, fatigue, and fever. Bone marrow biopsy shows promyelocytes with Auer rods. Cytogenetics reveals t(15;17). Which therapy is most effective?",
              "options": {
                "A": "Imatinib",
                "B": "All-trans retinoic acid (ATRA)",
                "C": "Methotrexate",
                "D": "Trastuzumab",
                "E": "Cyclophosphamide"
              },
              "answer": "B",
              "explanation": "t(15;17) in acute promyelocytic leukemia produces the PML-RARA fusion protein, treated with all-trans retinoic acid.",
              "image": null
            },
            {
              "id": "L7_Q5",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 65-year-old man presents with chronic lymphocytic leukemia. Cytogenetics reveals deletion of chromosome 17p. Which tumor suppressor gene is lost?",
              "options": {
                "A": "RB",
                "B": "TP53",
                "C": "APC",
                "D": "NF1",
                "E": "PTEN"
              },
              "answer": "B",
              "explanation": "Deletion of 17p causes loss of TP53, a critical tumor suppressor regulating apoptosis and DNA repair.",
              "image": null
            },
            {
              "id": "L7_Q10",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 12-year-old boy presents with a bone tumor in his femur. Cytogenetics reveals t(11;22). Which fusion gene is most likely present?",
              "options": {
                "A": "BCR-ABL",
                "B": "EWS-FLI1",
                "C": "MYC-IGH",
                "D": "PML-RARA",
                "E": "ALK-EML4"
              },
              "answer": "B",
              "explanation": "Ewing sarcoma is associated with t(11;22), leading to the EWS-FLI1 fusion gene.",
              "image": null
            },
            {
              "id": "L7_Q12",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 42-year-old man with chronic myeloid leukemia is started on imatinib. Which protein is inhibited by this therapy?",
              "options": {
                "A": "BCR-ABL tyrosine kinase",
                "B": "HER2 receptor",
                "C": "VEGF receptor",
                "D": "EGFR",
                "E": "ALK tyrosine kinase"
              },
              "answer": "A",
              "explanation": "Imatinib inhibits the BCR-ABL tyrosine kinase produced by the Philadelphia chromosome.",
              "image": null
            },
            {
              "id": "L7_Q15",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 60-year-old woman with lung adenocarcinoma is found to have an ALK translocation. Which drug is most effective?",
              "options": {
                "A": "Trastuzumab",
                "B": "Crizotinib",
                "C": "Rituximab",
                "D": "Bevacizumab",
                "E": "Imatinib"
              },
              "answer": "B",
              "explanation": "Crizotinib is an ALK tyrosine kinase inhibitor used in ALK-positive lung adenocarcinoma.",
              "image": null
            },
            {
              "id": "L7_Q17",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 7-year-old boy with Wilms tumor is found to have a mutation in WT1. Which type of gene is WT1?",
              "options": {
                "A": "Oncogene",
                "B": "Tumor suppressor",
                "C": "DNA repair enzyme",
                "D": "Cyclin",
                "E": "Signal transduction protein"
              },
              "answer": "B",
              "explanation": "WT1 is a tumor suppressor gene associated with Wilms tumor (nephroblastoma).",
              "image": null
            }
          ]
        },
        {
          "name": "Genomic Instability",
          "question_count": 2,
          "long_questions": [
            {
              "id": "L7_Q14",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 52-year-old man with colorectal carcinoma is found to have APC mutation. Which cellular pathway is dysregulated?",
              "options": {
                "A": "RAS/MAPK",
                "B": "Wnt/\u03b2-catenin",
                "C": "p53",
                "D": "Cyclin/CDK",
                "E": "Hedgehog"
              },
              "answer": "B",
              "explanation": "APC mutation leads to \u03b2-catenin accumulation and activation of Wnt signaling, promoting colon cancer.",
              "image": null
            },
            {
              "id": "L7_Q18",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 50-year-old man with small cell lung carcinoma is found to have p53 mutation. Which cellular function is lost?",
              "options": {
                "A": "Progression through G1/S checkpoint",
                "B": "DNA repair and apoptosis",
                "C": "Telomerase activity",
                "D": "Cyclin D expression",
                "E": "Rb phosphorylation"
              },
              "answer": "B",
              "explanation": "p53 regulates apoptosis and DNA repair; loss results in genomic instability.",
              "image": null
            }
          ]
        },
        {
          "name": "Gene Amplification: General Concept",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L7_Q13",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 10-year-old girl with neuroblastoma is found to have double minute chromosomes. What does this cytogenetic finding represent?",
              "options": {
                "A": "Chromosomal deletion",
                "B": "Chromosomal inversion",
                "C": "Gene amplification",
                "D": "Balanced translocation",
                "E": "Ring chromosome"
              },
              "answer": "C",
              "explanation": "Double minutes are small, extrachromosomal DNA fragments indicating gene amplification.",
              "image": null
            },
            {
              "stem": "A case is suspected to involve Gene Amplification: General Concept within the broader topic of Cytogenetics of Cancer. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Reliance on imaging alone"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "A case is suspected to involve Gene Amplification: General Concept within the broader topic of Cytogenetics of Cancer. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Reliance on imaging alone"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "MYCN Amplification",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L7_Q6",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 5-year-old boy presents with abdominal mass. Cytogenetics shows amplification of MYCN oncogene. Which cancer is most likely?",
              "options": {
                "A": "Neuroblastoma",
                "B": "Wilms tumor",
                "C": "Ewing sarcoma",
                "D": "Rhabdomyosarcoma",
                "E": "Hepatoblastoma"
              },
              "answer": "A",
              "explanation": "MYCN amplification is strongly associated with neuroblastoma and poor prognosis.",
              "image": null
            },
            {
              "stem": "A case is suspected to involve MYCN Amplification within the broader topic of Cytogenetics of Cancer. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Reliance on imaging alone",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "A case is suspected to involve MYCN Amplification within the broader topic of Cytogenetics of Cancer. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Reliance on imaging alone",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "HER2/neu (ERBB2) Amplification",
          "question_count": 2,
          "long_questions": [
            {
              "id": "L7_Q3",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 50-year-old woman with breast cancer is found to have HER2 gene amplification. Which targeted therapy is most appropriate?",
              "options": {
                "A": "Rituximab",
                "B": "Imatinib",
                "C": "Trastuzumab",
                "D": "Cetuximab",
                "E": "Bevacizumab"
              },
              "answer": "C",
              "explanation": "HER2 amplification is targeted with trastuzumab, a monoclonal antibody blocking HER2 signaling.",
              "image": null
            },
            {
              "id": "L7_Q11",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 50-year-old woman with breast cancer is treated with trastuzumab. Which cytogenetic abnormality is being targeted?",
              "options": {
                "A": "HER2 amplification",
                "B": "BCR-ABL fusion",
                "C": "PML-RARA fusion",
                "D": "MYC translocation",
                "E": "BCL2 translocation"
              },
              "answer": "A",
              "explanation": "HER2 amplification is specifically targeted by trastuzumab therapy.",
              "image": null
            }
          ]
        },
        {
          "name": "Oncogene vs Tumor Suppressor Gene Alterations",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L7_Q9",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 60-year-old man presents with a sarcoma. Cytogenetics reveals MDM2 gene amplification. Which tumor suppressor pathway is inactivated?",
              "options": {
                "A": "Rb",
                "B": "p53",
                "C": "APC",
                "D": "PTEN",
                "E": "NF1"
              },
              "answer": "B",
              "explanation": "MDM2 amplification increases degradation of p53, inactivating its tumor suppressor function.",
              "image": null
            },
            {
              "stem": "A case is suspected to involve Oncogene vs Tumor Suppressor Gene Alterations within the broader topic of Cytogenetics of Cancer. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "A case is suspected to involve Oncogene vs Tumor Suppressor Gene Alterations within the broader topic of Cytogenetics of Cancer. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Overview of Cancer Cytogenetics",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Overview of Cancer Cytogenetics within the broader topic of Cytogenetics of Cancer. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Reliance on imaging alone",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Overview of Cancer Cytogenetics, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Patient age alone",
                "B": "Evidence of invasion and metastatic potential",
                "C": "Lesion size alone",
                "D": "Presence of inflammation"
              },
              "answer": "B",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Detection of BCR-ABL",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Detection of BCR-ABL within the broader topic of Cytogenetics of Cancer. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Detection of BCR-ABL, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Evidence of invasion and metastatic potential",
                "B": "Lesion size alone",
                "C": "Presence of inflammation",
                "D": "Patient age alone"
              },
              "answer": "A",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Cyclin D1 Amplification",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Cyclin D1 Amplification within the broader topic of Cytogenetics of Cancer. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Reliance on imaging alone",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Cyclin D1 Amplification, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Lesion size alone",
                "B": "Patient age alone",
                "C": "Presence of inflammation",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "MDM2 Amplification",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve MDM2 Amplification within the broader topic of Cytogenetics of Cancer. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Reliance on imaging alone",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In MDM2 Amplification, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Presence of inflammation",
                "B": "Lesion size alone",
                "C": "Patient age alone",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Double Minutes and Extrachromosomal DNA",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Double Minutes and Extrachromosomal DNA within the broader topic of Cytogenetics of Cancer. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Integration of histology with molecular testing correlating with clinical context",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Reliance on imaging alone"
              },
              "answer": "B",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Double Minutes and Extrachromosomal DNA, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Evidence of invasion and metastatic potential",
                "B": "Patient age alone",
                "C": "Presence of inflammation",
                "D": "Lesion size alone"
              },
              "answer": "A",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        }
      ]
    },
    {
      "topic": "Foundations of Cancer Screening & Diagnosis",
      "subtopics": [
        {
          "name": "Principles of Population Screening",
          "question_count": 4,
          "long_questions": [
            {
              "id": "L8_Q1",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 52-year-old woman undergoes routine screening mammography. Which principle justifies screening for breast cancer in asymptomatic women?",
              "options": {
                "A": "High specificity",
                "B": "Presence of a latent stage",
                "C": "Cost-effectiveness",
                "D": "Universal acceptability",
                "E": "Ability to cure all detected cases"
              },
              "answer": "B",
              "explanation": "Effective screening requires a detectable preclinical latent stage where intervention can alter the disease course.",
              "image": null
            },
            {
              "id": "L8_Q5",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 42-year-old woman with breast cancer undergoes sentinel lymph node biopsy for staging. What is the main purpose of this procedure?",
              "options": {
                "A": "Determine prognosis and guide therapy",
                "B": "Cure the disease",
                "C": "Improve cosmetic outcomes",
                "D": "Prevent recurrence",
                "E": "Reduce radiation need"
              },
              "answer": "A",
              "explanation": "Sentinel lymph node biopsy helps assess nodal spread, guiding treatment and prognosis.",
              "image": null
            },
            {
              "id": "L8_Q12",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 50-year-old woman with a history of breast cancer asks about liquid biopsy. What is the principle of this test?",
              "options": {
                "A": "Detects circulating tumor DNA in blood",
                "B": "Detects occult blood in stool",
                "C": "Detects viral DNA in tissue",
                "D": "Detects exosomal proteins",
                "E": "Detects autoantibodies"
              },
              "answer": "A",
              "explanation": "Liquid biopsy detects circulating tumor DNA or tumor cells, enabling noninvasive monitoring of cancer.",
              "image": null
            },
            {
              "id": "L8_Q16",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 62-year-old man with hepatocellular carcinoma is monitored with a serum marker. Which marker is most appropriate?",
              "options": {
                "A": "AFP",
                "B": "CEA",
                "C": "CA-125",
                "D": "CA 19-9",
                "E": "PSA"
              },
              "answer": "A",
              "explanation": "Alpha-fetoprotein (AFP) is used to monitor hepatocellular carcinoma.",
              "image": null
            }
          ]
        },
        {
          "name": "Test Accuracy: Sensitivity and Specificity",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L8_Q3",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 45-year-old woman with a family history of breast cancer undergoes mammography. The test has high sensitivity but low specificity. What is the consequence?",
              "options": {
                "A": "High false negatives",
                "B": "High false positives",
                "C": "Low true positives",
                "D": "Low negative predictive value",
                "E": "High accuracy"
              },
              "answer": "B",
              "explanation": "Low specificity leads to more false positives, causing unnecessary anxiety and additional testing.",
              "image": null
            },
            {
              "id": "L8_Q9",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 62-year-old woman undergoes mammography. The test sensitivity is 85% and specificity is 90%. What does sensitivity represent?",
              "options": {
                "A": "Probability of a positive test if disease is present",
                "B": "Probability of a negative test if disease is absent",
                "C": "Probability that a positive test means disease is present",
                "D": "Probability that a negative test means no disease",
                "E": "Probability the test is reproducible"
              },
              "answer": "A",
              "explanation": "Sensitivity is the true positive rate: probability that the test detects disease when it is truly present.",
              "image": null
            },
            {
              "id": "L8_Q19",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 64-year-old woman undergoes a biopsy of a breast lesion. The biopsy is negative, but suspicion remains high. What is the next step?",
              "options": {
                "A": "No further testing",
                "B": "Repeat biopsy",
                "C": "Ignore due to high specificity",
                "D": "Treat empirically",
                "E": "CT scan only"
              },
              "answer": "B",
              "explanation": "A negative biopsy does not rule out cancer if suspicion remains; repeat biopsy is indicated.",
              "image": null
            }
          ]
        },
        {
          "name": "Biases in Screening",
          "question_count": 2,
          "long_questions": [
            {
              "id": "L8_Q6",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 70-year-old man undergoes prostate cancer screening with PSA testing. Which bias most likely inflates survival statistics?",
              "options": {
                "A": "Recall bias",
                "B": "Lead-time bias",
                "C": "Length bias",
                "D": "Selection bias",
                "E": "Observer bias"
              },
              "answer": "B",
              "explanation": "Lead-time bias occurs when earlier diagnosis falsely appears to prolong survival without changing the outcome.",
              "image": null
            },
            {
              "id": "L8_Q7",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 67-year-old woman is diagnosed with breast cancer through screening. The cancer is indolent. Which bias accounts for the apparent improved survival?",
              "options": {
                "A": "Lead-time bias",
                "B": "Length bias",
                "C": "Recall bias",
                "D": "Selection bias",
                "E": "Detection bias"
              },
              "answer": "B",
              "explanation": "Length bias occurs when screening preferentially detects slower-growing cancers that inherently have better outcomes.",
              "image": null
            }
          ]
        },
        {
          "name": "Lung Cancer Screening",
          "question_count": 8,
          "long_questions": [
            {
              "id": "L8_Q2",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 60-year-old man with a 40-pack-year smoking history asks about lung cancer screening. According to USPSTF guidelines, which test is recommended?",
              "options": {
                "A": "Chest X-ray",
                "B": "Annual chest CT with contrast",
                "C": "Annual low-dose CT scan",
                "D": "Annual MRI chest",
                "E": "Annual PET-CT"
              },
              "answer": "C",
              "explanation": "USPSTF recommends annual low-dose CT scans for high-risk individuals (50\u201380 years, >20 pack-year history, current smokers or quit within 15 years).",
              "image": null
            },
            {
              "id": "L8_Q4",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 65-year-old woman undergoes screening colonoscopy. What is the primary rationale for screening colorectal cancer?",
              "options": {
                "A": "High mortality rate",
                "B": "Presence of an early detectable adenoma-carcinoma sequence",
                "C": "High sensitivity of stool guaiac test",
                "D": "Low prevalence in elderly",
                "E": "Cost of treatment is low"
              },
              "answer": "B",
              "explanation": "Colorectal cancer develops from adenomas over many years, providing an opportunity for early detection and polyp removal.",
              "image": null
            },
            {
              "id": "L8_Q8",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 58-year-old man with a strong family history of colorectal cancer asks about stool DNA testing. What is the principle of this test?",
              "options": {
                "A": "Detection of occult blood",
                "B": "Detection of KRAS and APC mutations",
                "C": "Detection of cytogenetic translocations",
                "D": "Detection of viral DNA",
                "E": "Detection of serum tumor markers"
              },
              "answer": "B",
              "explanation": "Stool DNA testing detects mutations such as KRAS, APC, and microsatellite instability associated with colorectal cancer.",
              "image": null
            },
            {
              "id": "L8_Q10",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 55-year-old man undergoes a colonoscopy for screening. A polyp is found and removed. What is this procedure best classified as?",
              "options": {
                "A": "Primary prevention",
                "B": "Secondary prevention",
                "C": "Tertiary prevention",
                "D": "Quaternary prevention",
                "E": "Prophylactic surgery"
              },
              "answer": "B",
              "explanation": "Colonoscopy is secondary prevention: screening detects and removes precancerous lesions before cancer develops.",
              "image": null
            },
            {
              "id": "L8_Q11",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 60-year-old man presents with hematuria. Cystoscopy is performed to confirm bladder cancer. This diagnostic test is best classified as what type of prevention?",
              "options": {
                "A": "Primary",
                "B": "Secondary",
                "C": "Tertiary",
                "D": "Quaternary",
                "E": "Screening"
              },
              "answer": "C",
              "explanation": "Confirming and treating symptomatic disease is tertiary prevention.",
              "image": null
            },
            {
              "id": "L8_Q14",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 63-year-old woman with a family history of breast cancer undergoes BRCA1 testing. Her result is 'variant of uncertain significance.' How should this be managed?",
              "options": {
                "A": "Treat as pathogenic",
                "B": "Treat as benign",
                "C": "Not used for clinical decision-making",
                "D": "Immediate surgery",
                "E": "Used for family screening"
              },
              "answer": "C",
              "explanation": "Variants of uncertain significance should not guide management until reclassified.",
              "image": null
            },
            {
              "id": "L8_Q15",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 40-year-old woman undergoes cervical cancer screening. Which test is the primary method for early detection?",
              "options": {
                "A": "Pap smear",
                "B": "HPV DNA test",
                "C": "Colposcopy",
                "D": "Endometrial biopsy",
                "E": "Vaginal ultrasound"
              },
              "answer": "A",
              "explanation": "Pap smear detects cervical dysplasia before invasive cancer develops.",
              "image": null
            },
            {
              "id": "L8_Q17",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 70-year-old woman undergoes mammography. What is the 'number needed to screen' (NNS) concept?",
              "options": {
                "A": "Number of patients screened to detect one case",
                "B": "Number of patients screened to prevent one death",
                "C": "Number of false positives per test",
                "D": "Number of true positives per test",
                "E": "Number needed to treat"
              },
              "answer": "B",
              "explanation": "NNS represents the number of people who must be screened to prevent one death.",
              "image": null
            }
          ]
        },
        {
          "name": "Staging and Imaging",
          "question_count": 2,
          "long_questions": [
            {
              "id": "L8_Q13",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 55-year-old man with lung cancer is staged using PET-CT. What does staging primarily determine?",
              "options": {
                "A": "Histologic subtype",
                "B": "Response to chemotherapy",
                "C": "Extent of disease and prognosis",
                "D": "Underlying genetic cause",
                "E": "Radiation sensitivity"
              },
              "answer": "C",
              "explanation": "Staging determines the extent of spread and is a key determinant of prognosis and treatment planning.",
              "image": null
            },
            {
              "id": "L8_Q18",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 58-year-old man with colon cancer undergoes staging. Which imaging modality is best for detecting liver metastases?",
              "options": {
                "A": "Chest X-ray",
                "B": "Ultrasound",
                "C": "CT scan",
                "D": "PET scan",
                "E": "MRI"
              },
              "answer": "C",
              "explanation": "CT scan is the most widely used and effective method for detecting liver metastases in colorectal cancer.",
              "image": null
            }
          ]
        },
        {
          "name": "Predictive Values",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Predictive Values within the broader topic of Foundations of Cancer Screening & Diagnosis. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Predictive Values, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Presence of inflammation",
                "B": "Lesion size alone",
                "C": "Patient age alone",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Breast Cancer Screening Guidelines",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Breast Cancer Screening Guidelines within the broader topic of Foundations of Cancer Screening & Diagnosis. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Integration of histology with molecular testing correlating with clinical context",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Exclusion of biopsy to avoid tumor spread"
              },
              "answer": "B",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Breast Cancer Screening Guidelines, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Presence of inflammation",
                "B": "Lesion size alone",
                "C": "Evidence of invasion and metastatic potential",
                "D": "Patient age alone"
              },
              "answer": "C",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Other Cancer Screening Highlights",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Other Cancer Screening Highlights within the broader topic of Foundations of Cancer Screening & Diagnosis. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Reliance on imaging alone"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Other Cancer Screening Highlights, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Patient age alone",
                "B": "Lesion size alone",
                "C": "Evidence of invasion and metastatic potential",
                "D": "Presence of inflammation"
              },
              "answer": "C",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Diagnostic Workflow After Screening",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Diagnostic Workflow After Screening within the broader topic of Foundations of Cancer Screening & Diagnosis. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Reliance on imaging alone",
                "D": "Exclusion of biopsy to avoid tumor spread"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Diagnostic Workflow After Screening, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Patient age alone",
                "B": "Presence of inflammation",
                "C": "Evidence of invasion and metastatic potential",
                "D": "Lesion size alone"
              },
              "answer": "C",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        }
      ]
    },
    {
      "topic": "Foundations of Cancer Therapy",
      "subtopics": [
        {
          "name": "Overview of the Three Pillars",
          "question_count": 5,
          "long_questions": [
            {
              "id": "L9_Q1",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 55-year-old woman with breast cancer undergoes lumpectomy followed by adjuvant radiation therapy. Which of the following best describes the purpose of adjuvant radiation?",
              "options": {
                "A": "Cure microscopic residual disease",
                "B": "Reduce systemic recurrence",
                "C": "Provide pain relief only",
                "D": "Reverse chemotherapy toxicity",
                "E": "Replace surgery"
              },
              "answer": "A",
              "explanation": "Adjuvant radiation therapy is used after surgery to eradicate microscopic residual disease and reduce local recurrence.",
              "image": null
            },
            {
              "id": "L9_Q2",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 45-year-old man with testicular cancer undergoes orchiectomy followed by cisplatin-based chemotherapy. Which best describes the role of chemotherapy here?",
              "options": {
                "A": "Local control",
                "B": "Systemic therapy for micrometastases",
                "C": "Immunotherapy replacement",
                "D": "Replaces surgery",
                "E": "Used only for palliative purposes"
              },
              "answer": "B",
              "explanation": "Chemotherapy in testicular cancer is systemic therapy used to eliminate micrometastatic disease.",
              "image": null
            },
            {
              "id": "L9_Q12",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 62-year-old man undergoing chemotherapy develops neutropenic fever. Which is the best next step?",
              "options": {
                "A": "Hold chemotherapy only",
                "B": "Immediate broad-spectrum antibiotics",
                "C": "Prophylactic antivirals",
                "D": "Bone marrow transplant",
                "E": "Corticosteroids"
              },
              "answer": "B",
              "explanation": "Neutropenic fever is an oncologic emergency requiring immediate broad-spectrum antibiotics.",
              "image": null
            },
            {
              "id": "L9_Q15",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 66-year-old man undergoing chemotherapy develops tumor lysis syndrome. Which laboratory abnormalities are expected?",
              "options": {
                "A": "Hypercalcemia, hypokalemia",
                "B": "Hypocalcemia, hyperkalemia",
                "C": "Hypernatremia, hypophosphatemia",
                "D": "Hypoglycemia, hypernatremia",
                "E": "Hypermagnesemia, hyperchloremia"
              },
              "answer": "B",
              "explanation": "Tumor lysis syndrome causes hyperkalemia, hyperphosphatemia, hyperuricemia, and secondary hypocalcemia.",
              "image": null
            },
            {
              "id": "L9_Q19",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 72-year-old woman with metastatic breast cancer receives bisphosphonates. What is the purpose of this therapy?",
              "options": {
                "A": "Reduce bone metastasis-related complications",
                "B": "Enhance chemotherapy efficacy",
                "C": "Promote angiogenesis",
                "D": "Block PD-1 pathway",
                "E": "Induce apoptosis in T-cells"
              },
              "answer": "A",
              "explanation": "Bisphosphonates reduce skeletal-related events such as fractures and hypercalcemia in patients with bone metastases.",
              "image": null
            }
          ]
        },
        {
          "name": "Cancer Surgery",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L9_Q3",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 65-year-old man undergoes colectomy for colorectal carcinoma. Which term describes surgical removal of all detectable tumor with curative intent?",
              "options": {
                "A": "Cytoreductive surgery",
                "B": "Definitive surgery",
                "C": "Prophylactic surgery",
                "D": "Palliative surgery",
                "E": "Diagnostic surgery"
              },
              "answer": "B",
              "explanation": "Definitive surgery aims to remove the entire tumor mass with curative intent.",
              "image": null
            },
            {
              "id": "L9_Q10",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 48-year-old woman receives trastuzumab for breast cancer. Which monitoring is most important?",
              "options": {
                "A": "Liver function tests",
                "B": "Renal function tests",
                "C": "Echocardiogram",
                "D": "Pulmonary function tests",
                "E": "Bone density scan"
              },
              "answer": "C",
              "explanation": "Trastuzumab can cause cardiotoxicity; echocardiograms are required to monitor left ventricular function.",
              "image": null
            },
            {
              "id": "L9_Q13",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 55-year-old woman with advanced lung cancer receives palliative radiotherapy for bone pain. What is the purpose of this therapy?",
              "options": {
                "A": "Curative",
                "B": "Adjuvant",
                "C": "Neoadjuvant",
                "D": "Palliative",
                "E": "Prophylactic"
              },
              "answer": "D",
              "explanation": "Palliative therapy aims to relieve symptoms and improve quality of life in incurable cancer.",
              "image": null
            }
          ]
        },
        {
          "name": "Radiation Therapy: Mechanism",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L9_Q4",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 50-year-old woman with bulky cervical cancer undergoes radiation therapy. Which DNA lesion is primarily responsible for cancer cell death?",
              "options": {
                "A": "Thymine dimers",
                "B": "DNA double-strand breaks",
                "C": "Single nucleotide polymorphisms",
                "D": "Base mismatches",
                "E": "Methylation defects"
              },
              "answer": "B",
              "explanation": "Ionizing radiation causes DNA double-strand breaks, the most lethal form of DNA damage leading to apoptosis.",
              "image": null
            },
            {
              "id": "L9_Q5",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 62-year-old man with prostate cancer undergoes androgen deprivation therapy. Which mechanism underlies this treatment?",
              "options": {
                "A": "Blocks androgen receptor signaling",
                "B": "Destroys prostate tissue directly",
                "C": "Induces DNA alkylation",
                "D": "Blocks thymidylate synthase",
                "E": "Replaces testosterone"
              },
              "answer": "A",
              "explanation": "Androgen deprivation therapy slows tumor growth by blocking androgen receptor signaling in prostate cancer.",
              "image": null
            },
            {
              "id": "L9_Q6",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 70-year-old man receives external beam radiation therapy for lung cancer. Which phase of the cell cycle is most radiosensitive?",
              "options": {
                "A": "G0",
                "B": "G1",
                "C": "S",
                "D": "G2/M",
                "E": "Late G1"
              },
              "answer": "D",
              "explanation": "Cells are most radiosensitive in late G2 and M phases due to chromosomal condensation and reduced repair capacity.",
              "image": null
            }
          ]
        },
        {
          "name": "Chemo Drug Classes",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L9_Q7",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 54-year-old woman with breast cancer is started on doxorubicin. Which adverse effect requires close monitoring?",
              "options": {
                "A": "Renal toxicity",
                "B": "Pulmonary fibrosis",
                "C": "Cardiotoxicity",
                "D": "Peripheral neuropathy",
                "E": "Pancreatitis"
              },
              "answer": "C",
              "explanation": "Doxorubicin causes dose-dependent cardiotoxicity due to free radical formation.",
              "image": null
            },
            {
              "stem": "A case is suspected to involve Chemo Drug Classes within the broader topic of Foundations of Cancer Therapy. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Reliance on imaging alone",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "A case is suspected to involve Chemo Drug Classes within the broader topic of Foundations of Cancer Therapy. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Reliance on imaging alone",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Chemo Toxicities",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L9_Q17",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 40-year-old man receiving bleomycin develops dyspnea. Chest X-ray shows pulmonary fibrosis. Which adverse effect is most likely?",
              "options": {
                "A": "Cardiotoxicity",
                "B": "Renal toxicity",
                "C": "Pulmonary fibrosis",
                "D": "Neuropathy",
                "E": "Hepatotoxicity"
              },
              "answer": "C",
              "explanation": "Bleomycin toxicity leads to pulmonary fibrosis, a dose-limiting adverse effect.",
              "image": null
            },
            {
              "stem": "A case is suspected to involve Chemo Toxicities within the broader topic of Foundations of Cancer Therapy. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "A case is suspected to involve Chemo Toxicities within the broader topic of Foundations of Cancer Therapy. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Targeted Therapy",
          "question_count": 4,
          "long_questions": [
            {
              "id": "L9_Q9",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 68-year-old man with non-small cell lung cancer receives pembrolizumab. Which receptor is targeted?",
              "options": {
                "A": "PD-1",
                "B": "CTLA-4",
                "C": "HER2",
                "D": "EGFR",
                "E": "VEGF"
              },
              "answer": "A",
              "explanation": "Pembrolizumab is an immune checkpoint inhibitor targeting PD-1 to enhance T-cell activation against cancer.",
              "image": null
            },
            {
              "id": "L9_Q14",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 60-year-old man with CML is started on imatinib. Which molecular target is inhibited?",
              "options": {
                "A": "VEGF receptor",
                "B": "BCR-ABL tyrosine kinase",
                "C": "EGFR",
                "D": "ALK",
                "E": "HER2"
              },
              "answer": "B",
              "explanation": "Imatinib inhibits the BCR-ABL tyrosine kinase produced by the Philadelphia chromosome.",
              "image": null
            },
            {
              "id": "L9_Q16",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 58-year-old woman with breast cancer is placed on palbociclib. Which molecule is inhibited?",
              "options": {
                "A": "CDK4/6",
                "B": "mTOR",
                "C": "EGFR",
                "D": "VEGF receptor",
                "E": "BCR-ABL"
              },
              "answer": "A",
              "explanation": "Palbociclib is a CDK4/6 inhibitor used in hormone receptor-positive, HER2-negative breast cancer.",
              "image": null
            },
            {
              "id": "L9_Q18",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 68-year-old man with renal cell carcinoma is treated with bevacizumab. Which pathway is inhibited?",
              "options": {
                "A": "VEGF signaling",
                "B": "EGFR signaling",
                "C": "HER2 signaling",
                "D": "CDK4/6",
                "E": "BCR-ABL"
              },
              "answer": "A",
              "explanation": "Bevacizumab is an anti-VEGF antibody that inhibits angiogenesis in tumors.",
              "image": null
            }
          ]
        },
        {
          "name": "Hormone Therapy",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L9_Q8",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 40-year-old woman receives tamoxifen for ER+ breast cancer. Which adverse effect is she at risk for?",
              "options": {
                "A": "Osteoporosis",
                "B": "Endometrial carcinoma",
                "C": "Breast cancer recurrence",
                "D": "Ovarian failure",
                "E": "Renal cell carcinoma"
              },
              "answer": "B",
              "explanation": "Tamoxifen acts as an estrogen agonist in the endometrium, increasing risk of endometrial carcinoma.",
              "image": null
            },
            {
              "stem": "A case is suspected to involve Hormone Therapy within the broader topic of Foundations of Cancer Therapy. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Integration of histology with molecular testing correlating with clinical context",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Reliance on imaging alone"
              },
              "answer": "B",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "A case is suspected to involve Hormone Therapy within the broader topic of Foundations of Cancer Therapy. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Integration of histology with molecular testing correlating with clinical context",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Reliance on imaging alone"
              },
              "answer": "B",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Immunotherapy",
          "question_count": 2,
          "long_questions": [
            {
              "id": "L9_Q11",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 42-year-old woman with ovarian cancer receives cisplatin. Which adverse effect is most characteristic?",
              "options": {
                "A": "Nephrotoxicity",
                "B": "Cardiotoxicity",
                "C": "Pulmonary fibrosis",
                "D": "Cerebellar toxicity",
                "E": "Endometrial carcinoma"
              },
              "answer": "A",
              "explanation": "Cisplatin causes nephrotoxicity and requires prehydration protocols.",
              "image": null
            },
            {
              "id": "L9_Q20",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 55-year-old man with B-cell lymphoma receives rituximab. Which molecule is targeted?",
              "options": {
                "A": "CD19",
                "B": "CD20",
                "C": "CD30",
                "D": "CD52",
                "E": "CD33"
              },
              "answer": "B",
              "explanation": "Rituximab is an anti-CD20 monoclonal antibody used in B-cell lymphomas and autoimmune diseases.",
              "image": null
            }
          ]
        },
        {
          "name": "Radiation Modalities",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Radiation Modalities within the broader topic of Foundations of Cancer Therapy. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Integration of histology with molecular testing correlating with clinical context",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Reliance on imaging alone"
              },
              "answer": "B",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Radiation Modalities, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Presence of inflammation",
                "B": "Patient age alone",
                "C": "Lesion size alone",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "5 R\u2019s of Radiobiology",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve 5 R\u2019s of Radiobiology within the broader topic of Foundations of Cancer Therapy. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Serum tumor markers alone establish diagnosis",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Reliance on imaging alone",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In 5 R\u2019s of Radiobiology, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Presence of inflammation",
                "B": "Patient age alone",
                "C": "Evidence of invasion and metastatic potential",
                "D": "Lesion size alone"
              },
              "answer": "C",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Chemotherapy: Principles",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Chemotherapy: Principles within the broader topic of Foundations of Cancer Therapy. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Reliance on imaging alone",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Chemotherapy: Principles, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Patient age alone",
                "B": "Evidence of invasion and metastatic potential",
                "C": "Presence of inflammation",
                "D": "Lesion size alone"
              },
              "answer": "B",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Multidisciplinary and Personalized Therapy",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Multidisciplinary and Personalized Therapy within the broader topic of Foundations of Cancer Therapy. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Serum tumor markers alone establish diagnosis",
                "B": "Integration of histology with molecular testing correlating with clinical context",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Reliance on imaging alone"
              },
              "answer": "B",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Multidisciplinary and Personalized Therapy, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Presence of inflammation",
                "B": "Patient age alone",
                "C": "Evidence of invasion and metastatic potential",
                "D": "Lesion size alone"
              },
              "answer": "C",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        }
      ]
    },
    {
      "topic": "Cancer Survival Mechanisms",
      "subtopics": [
        {
          "name": "Other / Unclassified",
          "question_count": 20,
          "long_questions": [
            {
              "id": "L10_Q1",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 55-year-old man with colon cancer is found to have a KRAS mutation. Which hallmark of cancer does this mutation most directly promote?",
              "options": {
                "A": "Inducing angiogenesis",
                "B": "Sustained proliferative signaling",
                "C": "Evading immune destruction",
                "D": "Resisting apoptosis",
                "E": "Deregulating cellular metabolism"
              },
              "answer": "B",
              "explanation": "KRAS mutations lead to constitutive activation of growth signaling pathways, driving uncontrolled proliferation.",
              "image": null
            },
            {
              "id": "L10_Q2",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 40-year-old woman with breast cancer is found to have loss of p53 function. Which hallmark of cancer is most affected?",
              "options": {
                "A": "Sustained proliferation",
                "B": "Replicative immortality",
                "C": "Resisting apoptosis",
                "D": "Evading growth suppression",
                "E": "Genomic instability"
              },
              "answer": "E",
              "explanation": "Loss of p53 causes genomic instability by impairing DNA repair and apoptosis, allowing accumulation of mutations.",
              "image": null
            },
            {
              "id": "L10_Q3",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 65-year-old man with chronic myelogenous leukemia has the Philadelphia chromosome. Which hallmark of cancer does this primarily illustrate?",
              "options": {
                "A": "Evading immune detection",
                "B": "Sustained proliferative signaling",
                "C": "Inducing angiogenesis",
                "D": "Avoiding growth suppression",
                "E": "Deregulating energy metabolism"
              },
              "answer": "B",
              "explanation": "BCR-ABL fusion protein is a constitutively active tyrosine kinase that promotes sustained proliferative signaling.",
              "image": null
            },
            {
              "id": "L10_Q4",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 50-year-old woman with breast cancer is treated with a CDK4/6 inhibitor. Which hallmark of cancer does this therapy target?",
              "options": {
                "A": "Inducing angiogenesis",
                "B": "Avoiding immune detection",
                "C": "Evading growth suppression",
                "D": "Sustained proliferative signaling",
                "E": "Enabling replicative immortality"
              },
              "answer": "C",
              "explanation": "CDK4/6 inhibitors prevent Rb phosphorylation, enforcing the G1/S checkpoint and restoring growth suppression.",
              "image": null
            },
            {
              "id": "L10_Q5",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 60-year-old man with melanoma responds well to immune checkpoint inhibitor therapy. Which hallmark of cancer is being overcome?",
              "options": {
                "A": "Inducing angiogenesis",
                "B": "Resisting apoptosis",
                "C": "Evading immune destruction",
                "D": "Sustained proliferative signaling",
                "E": "Replicative immortality"
              },
              "answer": "C",
              "explanation": "Immune checkpoint inhibitors (anti-PD-1, anti-CTLA-4) restore T-cell activity, overcoming immune evasion by tumor cells.",
              "image": null
            },
            {
              "id": "L10_Q6",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 55-year-old woman with glioblastoma is treated with bevacizumab. Which hallmark of cancer does this therapy target?",
              "options": {
                "A": "Sustained proliferation",
                "B": "Inducing angiogenesis",
                "C": "Resisting apoptosis",
                "D": "Avoiding immune detection",
                "E": "Deregulating metabolism"
              },
              "answer": "B",
              "explanation": "Bevacizumab blocks VEGF signaling, targeting tumor-induced angiogenesis.",
              "image": null
            },
            {
              "id": "L10_Q7",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 45-year-old woman with ovarian cancer has telomerase activation. Which hallmark of cancer does this represent?",
              "options": {
                "A": "Resisting apoptosis",
                "B": "Enabling replicative immortality",
                "C": "Inducing angiogenesis",
                "D": "Sustained proliferation",
                "E": "Deregulating metabolism"
              },
              "answer": "B",
              "explanation": "Telomerase activation maintains telomere length, allowing limitless replicative potential.",
              "image": null
            },
            {
              "id": "L10_Q8",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 50-year-old man with small cell lung cancer exhibits high BCL2 expression. Which hallmark of cancer is represented?",
              "options": {
                "A": "Evading growth suppression",
                "B": "Sustained proliferation",
                "C": "Resisting apoptosis",
                "D": "Inducing angiogenesis",
                "E": "Avoiding immune detection"
              },
              "answer": "C",
              "explanation": "BCL2 overexpression prevents apoptosis by blocking mitochondrial cytochrome c release.",
              "image": null
            },
            {
              "id": "L10_Q9",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 60-year-old woman with breast cancer develops cachexia. Which mechanism best explains this phenomenon?",
              "options": {
                "A": "IL-1 mediated fever",
                "B": "TNF-\u03b1 and IL-6 induced catabolism",
                "C": "VEGF-induced angiogenesis",
                "D": "Increased telomerase activity",
                "E": "p53 mutation"
              },
              "answer": "B",
              "explanation": "Cachexia is mediated by cytokines (TNF-\u03b1, IL-6, IL-1) promoting catabolism and muscle wasting.",
              "image": null
            },
            {
              "id": "L10_Q10",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 48-year-old man with colon cancer demonstrates the Warburg effect. Which metabolic change is seen?",
              "options": {
                "A": "Preferential fatty acid oxidation",
                "B": "Aerobic glycolysis",
                "C": "Anaerobic respiration only",
                "D": "Decreased glucose uptake",
                "E": "Reduced lactic acid production"
              },
              "answer": "B",
              "explanation": "The Warburg effect is a shift toward aerobic glycolysis, producing lactate even in the presence of oxygen.",
              "image": null
            },
            {
              "id": "L10_Q11",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 42-year-old woman with cervical cancer due to HPV infection has E6 and E7 viral proteins. Which hallmark is represented?",
              "options": {
                "A": "Sustained proliferation",
                "B": "Evading growth suppression",
                "C": "Resisting apoptosis",
                "D": "Immune evasion",
                "E": "Deregulated metabolism"
              },
              "answer": "B",
              "explanation": "HPV E6 inactivates p53 and E7 inactivates Rb, allowing cells to bypass growth suppression.",
              "image": null
            },
            {
              "id": "L10_Q12",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 65-year-old man with pancreatic cancer develops extensive liver metastases. Which hallmark of cancer is this an example of?",
              "options": {
                "A": "Inducing angiogenesis",
                "B": "Activating invasion and metastasis",
                "C": "Resisting apoptosis",
                "D": "Replicative immortality",
                "E": "Sustained proliferation"
              },
              "answer": "B",
              "explanation": "Spread to distant organs represents activation of invasion and metastasis.",
              "image": null
            },
            {
              "id": "L10_Q13",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 70-year-old man with prostate cancer is found to have loss of PTEN. Which hallmark of cancer is promoted by PTEN loss?",
              "options": {
                "A": "Resisting apoptosis",
                "B": "Sustained proliferative signaling",
                "C": "Inducing angiogenesis",
                "D": "Evading immune detection",
                "E": "Replicative immortality"
              },
              "answer": "B",
              "explanation": "PTEN loss enhances PI3K/AKT signaling, promoting sustained proliferative signaling.",
              "image": null
            },
            {
              "id": "L10_Q14",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 55-year-old woman with melanoma responds poorly to anti-PD-1 therapy due to lack of T-cell infiltration. Which immune phenomenon explains this resistance?",
              "options": {
                "A": "T-cell exhaustion",
                "B": "Immune ignorance",
                "C": "Immune surveillance",
                "D": "Immune activation",
                "E": "Cytotoxic T-cell hyperactivation"
              },
              "answer": "B",
              "explanation": "Immune ignorance occurs when T-cells do not infiltrate the tumor, leading to resistance to checkpoint inhibitors.",
              "image": null
            },
            {
              "id": "L10_Q15",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 64-year-old man with glioblastoma develops mutations in IDH1, leading to accumulation of 2-hydroxyglutarate. Which hallmark of cancer does this represent?",
              "options": {
                "A": "Resisting apoptosis",
                "B": "Inducing angiogenesis",
                "C": "Deregulating cellular metabolism",
                "D": "Replicative immortality",
                "E": "Immune evasion"
              },
              "answer": "C",
              "explanation": "Mutated IDH alters metabolism, producing oncometabolites that contribute to cancer progression.",
              "image": null
            },
            {
              "id": "L10_Q16",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 50-year-old woman with ovarian cancer receives a PARP inhibitor. This drug exploits which hallmark of cancer?",
              "options": {
                "A": "Evading growth suppression",
                "B": "Defective DNA repair",
                "C": "Resisting apoptosis",
                "D": "Inducing angiogenesis",
                "E": "Sustained proliferation"
              },
              "answer": "B",
              "explanation": "PARP inhibitors target tumor cells with homologous recombination repair deficiency (e.g., BRCA mutations).",
              "image": null
            },
            {
              "id": "L10_Q17",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 70-year-old man with hepatocellular carcinoma has increased VEGF expression. Which hallmark of cancer does this promote?",
              "options": {
                "A": "Resisting apoptosis",
                "B": "Inducing angiogenesis",
                "C": "Immune evasion",
                "D": "Sustained proliferation",
                "E": "Deregulating metabolism"
              },
              "answer": "B",
              "explanation": "VEGF stimulates angiogenesis, providing blood supply for tumor growth.",
              "image": null
            },
            {
              "id": "L10_Q18",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 48-year-old man with non-small cell lung cancer receives osimertinib for EGFR mutation. Which hallmark of cancer is being targeted?",
              "options": {
                "A": "Sustained proliferation",
                "B": "Resisting apoptosis",
                "C": "Replicative immortality",
                "D": "Immune evasion",
                "E": "Deregulating metabolism"
              },
              "answer": "A",
              "explanation": "EGFR inhibitors block sustained proliferative signaling in EGFR-mutated tumors.",
              "image": null
            },
            {
              "id": "L10_Q19",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 55-year-old man with pancreatic cancer has mutations in SMAD4. Which hallmark of cancer is most directly impaired?",
              "options": {
                "A": "Evading growth suppression",
                "B": "Sustained proliferation",
                "C": "Inducing angiogenesis",
                "D": "Immune evasion",
                "E": "Resisting apoptosis"
              },
              "answer": "A",
              "explanation": "SMAD4 is part of the TGF-\u03b2 pathway, which normally suppresses growth. Mutation allows evasion of growth suppression.",
              "image": null
            },
            {
              "id": "L10_Q20",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 62-year-old woman with breast cancer has overexpression of GLUT1 transporters. Which hallmark of cancer is this most consistent with?",
              "options": {
                "A": "Evading growth suppression",
                "B": "Deregulating cellular metabolism",
                "C": "Inducing angiogenesis",
                "D": "Resisting apoptosis",
                "E": "Immune evasion"
              },
              "answer": "B",
              "explanation": "Overexpression of glucose transporters reflects metabolic reprogramming (Warburg effect).",
              "image": null
            }
          ]
        }
      ]
    },
    {
      "topic": "Individualizing Care of Cancer Patients",
      "subtopics": [
        {
          "name": "Other / Unclassified",
          "question_count": 19,
          "long_questions": [
            {
              "id": "L11_Q1",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 55-year-old woman with breast cancer undergoes genomic testing with Oncotype DX. Which is the primary purpose of this test?",
              "options": {
                "A": "Predict drug toxicity",
                "B": "Determine tumor stage",
                "C": "Guide chemotherapy benefit",
                "D": "Detect inherited BRCA mutations",
                "E": "Monitor treatment response"
              },
              "answer": "C",
              "explanation": "Oncotype DX evaluates gene expression to estimate recurrence risk and benefit from chemotherapy.",
              "image": null
            },
            {
              "id": "L11_Q2",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 45-year-old man with metastatic melanoma undergoes testing for PD-L1 expression. Why is this test performed?",
              "options": {
                "A": "Predict response to immunotherapy",
                "B": "Predict chemotherapy side effects",
                "C": "Guide radiation dosing",
                "D": "Determine stage",
                "E": "Identify inherited mutations"
              },
              "answer": "A",
              "explanation": "PD-L1 testing stratifies patients for immunotherapy, as high expression correlates with response to checkpoint inhibitors.",
              "image": null
            },
            {
              "id": "L11_Q3",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 35-year-old woman with ovarian cancer undergoes genetic testing for BRCA mutations. How would this result influence therapy?",
              "options": {
                "A": "Guide radiation therapy",
                "B": "Determine need for immunotherapy",
                "C": "Eligibility for PARP inhibitors",
                "D": "Exclude chemotherapy",
                "E": "Assess tumor grade"
              },
              "answer": "C",
              "explanation": "BRCA-mutated tumors have homologous recombination repair deficiency and respond well to PARP inhibitors.",
              "image": null
            },
            {
              "id": "L11_Q4",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 50-year-old man with colon cancer is treated with 5-FU and develops severe toxicity. Genetic testing reveals DPD deficiency. What explains this reaction?",
              "options": {
                "A": "Increased drug metabolism",
                "B": "Impaired drug catabolism",
                "C": "Increased DNA repair capacity",
                "D": "Immune checkpoint inhibition",
                "E": "Enhanced angiogenesis"
              },
              "answer": "B",
              "explanation": "Dihydropyrimidine dehydrogenase (DPD) deficiency prevents catabolism of 5-FU, causing severe toxicity.",
              "image": null
            },
            {
              "id": "L11_Q5",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 48-year-old man with colon cancer undergoes pharmacogenomic testing. He is found to have UGT1A1 polymorphism. Which chemotherapy drug requires dose adjustment?",
              "options": {
                "A": "Irinotecan",
                "B": "5-FU",
                "C": "Methotrexate",
                "D": "Cyclophosphamide",
                "E": "Cisplatin"
              },
              "answer": "A",
              "explanation": "UGT1A1 polymorphisms impair irinotecan metabolism, increasing risk of neutropenia and diarrhea.",
              "image": null
            },
            {
              "id": "L11_Q6",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 60-year-old woman with breast cancer tests positive for HER2 amplification. Which therapy is most effective?",
              "options": {
                "A": "Rituximab",
                "B": "Trastuzumab",
                "C": "Bevacizumab",
                "D": "Cetuximab",
                "E": "Imatinib"
              },
              "answer": "B",
              "explanation": "HER2 amplification in breast cancer is targeted by trastuzumab, a monoclonal antibody.",
              "image": null
            },
            {
              "id": "L11_Q7",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 40-year-old man with lung adenocarcinoma is tested for EGFR mutations. Why is this important?",
              "options": {
                "A": "Guides use of tyrosine kinase inhibitors",
                "B": "Guides use of checkpoint inhibitors",
                "C": "Predicts radiation resistance",
                "D": "Indicates poor prognosis only",
                "E": "Determines stage"
              },
              "answer": "A",
              "explanation": "EGFR mutation-positive lung cancers respond well to EGFR tyrosine kinase inhibitors (e.g., erlotinib, osimertinib).",
              "image": null
            },
            {
              "id": "L11_Q8",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 50-year-old man with colorectal cancer undergoes KRAS mutation testing. Why is this performed before giving cetuximab?",
              "options": {
                "A": "Cetuximab is effective only in KRAS-mutant tumors",
                "B": "Cetuximab is effective only in KRAS-wild type tumors",
                "C": "Cetuximab is effective regardless of KRAS status",
                "D": "Cetuximab is contraindicated in colon cancer",
                "E": "Cetuximab causes severe toxicity in KRAS wild type"
              },
              "answer": "B",
              "explanation": "Cetuximab is effective only in KRAS-wild type colorectal cancer, as KRAS mutations bypass EGFR blockade.",
              "image": null
            },
            {
              "id": "L11_Q9",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 52-year-old woman with lymphoma undergoes CAR T-cell therapy. Which best describes this treatment?",
              "options": {
                "A": "Ex vivo expansion of patient\u2019s T-cells genetically modified to target tumor antigen",
                "B": "In vivo checkpoint blockade therapy",
                "C": "Direct monoclonal antibody infusion",
                "D": "Nonspecific cytokine infusion",
                "E": "Autologous stem cell transplantation"
              },
              "answer": "A",
              "explanation": "CAR T-cell therapy involves engineering patient\u2019s T-cells to express chimeric antigen receptors that target tumor cells.",
              "image": null
            },
            {
              "id": "L11_Q10",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 65-year-old man with lung cancer is found to have ALK translocation. Which therapy is indicated?",
              "options": {
                "A": "Trastuzumab",
                "B": "Rituximab",
                "C": "Crizotinib",
                "D": "Cetuximab",
                "E": "Bevacizumab"
              },
              "answer": "C",
              "explanation": "ALK rearrangements in lung cancer are treated with ALK inhibitors such as crizotinib.",
              "image": null
            },
            {
              "id": "L11_Q11",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 68-year-old woman with breast cancer undergoes pharmacogenomic testing. CYP2D6 polymorphisms affect metabolism of which drug?",
              "options": {
                "A": "Tamoxifen",
                "B": "Trastuzumab",
                "C": "Bevacizumab",
                "D": "Rituximab",
                "E": "Cetuximab"
              },
              "answer": "A",
              "explanation": "Tamoxifen is metabolized to its active form by CYP2D6. Poor metabolizers may not benefit fully from therapy.",
              "image": null
            },
            {
              "id": "L11_Q12",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 62-year-old woman with melanoma undergoes BRAF mutation testing. Which drug is indicated if V600E mutation is present?",
              "options": {
                "A": "Imatinib",
                "B": "Vemurafenib",
                "C": "Rituximab",
                "D": "Bevacizumab",
                "E": "Erlotinib"
              },
              "answer": "B",
              "explanation": "Vemurafenib targets BRAF V600E mutations in melanoma.",
              "image": null
            },
            {
              "id": "L11_Q13",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 55-year-old man with pancreatic cancer undergoes testing for mismatch repair deficiency. Why is this clinically relevant?",
              "options": {
                "A": "Indicates poor prognosis only",
                "B": "Predicts response to PD-1 inhibitors",
                "C": "Contraindicates surgery",
                "D": "Requires PARP inhibitors",
                "E": "Guides radiation dosing"
              },
              "answer": "B",
              "explanation": "Mismatch repair-deficient tumors are hypermutated and respond well to PD-1 immune checkpoint inhibitors.",
              "image": null
            },
            {
              "id": "L11_Q14",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 60-year-old man with AML undergoes FLT3 mutation testing. Which therapy is effective against FLT3-mutated AML?",
              "options": {
                "A": "Midostaurin",
                "B": "Rituximab",
                "C": "Trastuzumab",
                "D": "Bevacizumab",
                "E": "Cetuximab"
              },
              "answer": "A",
              "explanation": "FLT3 mutations in AML are targeted with tyrosine kinase inhibitors such as midostaurin.",
              "image": null
            },
            {
              "id": "L11_Q15",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 70-year-old woman with breast cancer is evaluated for CYP2C9 polymorphisms before starting warfarin. This illustrates which principle of personalized medicine?",
              "options": {
                "A": "Predicting drug metabolism",
                "B": "Detecting tumor mutations",
                "C": "Determining tumor stage",
                "D": "Guiding surgery type",
                "E": "Monitoring disease progression"
              },
              "answer": "A",
              "explanation": "CYP2C9 polymorphisms affect warfarin metabolism, demonstrating pharmacogenomics in therapy adjustment.",
              "image": null
            },
            {
              "id": "L11_Q16",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 66-year-old man with glioblastoma receives tumor sequencing that identifies MGMT promoter methylation. Why is this important?",
              "options": {
                "A": "Predicts sensitivity to alkylating agents",
                "B": "Indicates HER2 positivity",
                "C": "Determines eligibility for immunotherapy",
                "D": "Contraindicates chemotherapy",
                "E": "Predicts tamoxifen response"
              },
              "answer": "A",
              "explanation": "MGMT methylation silences DNA repair, making glioblastomas more sensitive to alkylating agents like temozolomide.",
              "image": null
            },
            {
              "id": "L11_Q17",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 50-year-old man with colon cancer has DPYD gene mutation. What is the clinical significance?",
              "options": {
                "A": "Increased toxicity from irinotecan",
                "B": "Increased toxicity from 5-FU",
                "C": "Resistance to imatinib",
                "D": "Resistance to rituximab",
                "E": "Increased efficacy of trastuzumab"
              },
              "answer": "B",
              "explanation": "DPYD mutations impair 5-FU metabolism, causing severe toxicity.",
              "image": null
            },
            {
              "id": "L11_Q18",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 68-year-old man with prostate cancer undergoes AR-V7 mutation testing. Why is this clinically relevant?",
              "options": {
                "A": "Predicts resistance to androgen receptor inhibitors",
                "B": "Indicates PARP inhibitor sensitivity",
                "C": "Guides radiation therapy",
                "D": "Predicts tamoxifen response",
                "E": "Indicates trastuzumab resistance"
              },
              "answer": "A",
              "explanation": "AR-V7 mutations confer resistance to androgen receptor inhibitors like enzalutamide and abiraterone.",
              "image": null
            },
            {
              "id": "L11_Q19",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 72-year-old woman with pancreatic cancer undergoes next-generation sequencing. STK11 mutation is identified. Why is this significant?",
              "options": {
                "A": "Predicts chemotherapy resistance",
                "B": "Predicts immunotherapy resistance",
                "C": "Predicts radiation sensitivity",
                "D": "Indicates HER2 positivity",
                "E": "Indicates improved prognosis"
              },
              "answer": "B",
              "explanation": "STK11 mutations predict resistance to immunotherapy in pancreatic and lung cancers.",
              "image": null
            }
          ]
        }
      ]
    },
    {
      "topic": "Genetic Counseling of Familial Cancers",
      "subtopics": [
        {
          "name": "Overview of Genetic Counseling",
          "question_count": 2,
          "long_questions": [
            {
              "id": "L12_Q7",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 35-year-old woman undergoes genetic testing for BRCA1 mutation. She asks about the management of her daughters. What is the best recommendation?",
              "options": {
                "A": "Immediate mastectomy at age 12",
                "B": "Genetic counseling and testing when older",
                "C": "Ignore due to uncertainty",
                "D": "Treat as affected by default",
                "E": "Start mammography at age 20 without testing"
              },
              "answer": "B",
              "explanation": "Relatives of patients with known mutations should undergo genetic counseling and testing at appropriate age.",
              "image": null
            },
            {
              "id": "L12_Q17",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 35-year-old man presents with hemangioblastomas, renal cell carcinoma, and pheochromocytoma. Genetic testing confirms VHL syndrome. Which inheritance pattern is seen?",
              "options": {
                "A": "Autosomal dominant",
                "B": "Autosomal recessive",
                "C": "X-linked",
                "D": "Mitochondrial",
                "E": "De novo only"
              },
              "answer": "A",
              "explanation": "VHL syndrome is inherited in an autosomal dominant manner.",
              "image": null
            }
          ]
        },
        {
          "name": "Hereditary vs Familial vs Sporadic Cancer",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L12_Q8",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 45-year-old man with pancreatic cancer is found to have a germline BRCA2 mutation. Which therapy may be beneficial?",
              "options": {
                "A": "EGFR inhibitors",
                "B": "Checkpoint inhibitors",
                "C": "PARP inhibitors",
                "D": "VEGF inhibitors",
                "E": "ALK inhibitors"
              },
              "answer": "C",
              "explanation": "BRCA mutations impair homologous recombination repair; PARP inhibitors exploit this deficiency.",
              "image": null
            },
            {
              "stem": "A case is suspected to involve Hereditary vs Familial vs Sporadic Cancer within the broader topic of Genetic Counseling of Familial Cancers. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Reliance on imaging alone"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "A case is suspected to involve Hereditary vs Familial vs Sporadic Cancer within the broader topic of Genetic Counseling of Familial Cancers. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Reliance on imaging alone"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Common Hereditary Cancer Syndromes",
          "question_count": 13,
          "long_questions": [
            {
              "id": "L12_Q1",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 35-year-old woman presents with bilateral breast cancer at age 35. Her mother had ovarian cancer at age 42. Which inherited syndrome is most likely?",
              "options": {
                "A": "Lynch syndrome",
                "B": "Li-Fraumeni syndrome",
                "C": "Hereditary breast and ovarian cancer (BRCA1/2)",
                "D": "Familial adenomatous polyposis",
                "E": "Cowden syndrome"
              },
              "answer": "C",
              "explanation": "Young onset bilateral breast cancer and ovarian cancer strongly suggest BRCA1/2 mutation (HBOC).",
              "image": null
            },
            {
              "id": "L12_Q2",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 45-year-old man has colorectal cancer at age 45. His father had endometrial cancer at age 50. Genetic testing reveals an MSH2 mutation. Which syndrome is this?",
              "options": {
                "A": "Familial adenomatous polyposis",
                "B": "Li-Fraumeni syndrome",
                "C": "Lynch syndrome",
                "D": "Peutz-Jeghers syndrome",
                "E": "HBOC"
              },
              "answer": "C",
              "explanation": "Mismatch repair gene mutations (e.g., MSH2, MLH1, MSH6, PMS2) cause Lynch syndrome (HNPCC).",
              "image": null
            },
            {
              "id": "L12_Q3",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 30-year-old man with 200 adenomatous polyps on colonoscopy is diagnosed with familial adenomatous polyposis (FAP). Which gene is mutated?",
              "options": {
                "A": "APC",
                "B": "MLH1",
                "C": "TP53",
                "D": "BRCA2",
                "E": "VHL"
              },
              "answer": "A",
              "explanation": "FAP is caused by germline mutations in the APC tumor suppressor gene.",
              "image": null
            },
            {
              "id": "L12_Q4",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 28-year-old woman has a family history of Li-Fraumeni syndrome. Which gene mutation is associated?",
              "options": {
                "A": "TP53",
                "B": "RB1",
                "C": "BRCA1",
                "D": "MLH1",
                "E": "NF1"
              },
              "answer": "A",
              "explanation": "Li-Fraumeni syndrome involves germline TP53 mutations, leading to multiple early cancers.",
              "image": null
            },
            {
              "id": "L12_Q5",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 45-year-old woman with endometrial cancer is suspected to have Lynch syndrome. Which additional cancer is she at risk for?",
              "options": {
                "A": "Hepatocellular carcinoma",
                "B": "Colorectal cancer",
                "C": "Thyroid cancer",
                "D": "Glioblastoma",
                "E": "Acute leukemia"
              },
              "answer": "B",
              "explanation": "Lynch syndrome increases risk for colorectal, endometrial, ovarian, gastric, pancreatic, and urothelial cancers.",
              "image": null
            },
            {
              "id": "L12_Q6",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 60-year-old man with a history of renal cell carcinoma is found to have VHL mutation. Which other tumor is associated?",
              "options": {
                "A": "Pheochromocytoma",
                "B": "Breast cancer",
                "C": "Colon cancer",
                "D": "Endometrial carcinoma",
                "E": "Glioblastoma"
              },
              "answer": "A",
              "explanation": "Von Hippel-Lindau syndrome predisposes to renal cell carcinoma, pheochromocytomas, and hemangioblastomas.",
              "image": null
            },
            {
              "id": "L12_Q9",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 30-year-old man with multiple osteomas, epidermoid cysts, and dental abnormalities is diagnosed with Gardner syndrome. Which cancer is he at risk for?",
              "options": {
                "A": "Pancreatic cancer",
                "B": "Colorectal cancer",
                "C": "Glioblastoma",
                "D": "Renal cell carcinoma",
                "E": "Prostate cancer"
              },
              "answer": "B",
              "explanation": "Gardner syndrome is a variant of FAP associated with colorectal cancer, osteomas, and soft tissue tumors.",
              "image": null
            },
            {
              "id": "L12_Q11",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 55-year-old man presents with pheochromocytoma and medullary thyroid carcinoma. Genetic testing reveals RET mutation. Which syndrome is this?",
              "options": {
                "A": "MEN1",
                "B": "MEN2A",
                "C": "MEN2B",
                "D": "VHL",
                "E": "NF1"
              },
              "answer": "B",
              "explanation": "RET mutations are associated with MEN2 syndromes; MEN2A includes pheochromocytoma and medullary thyroid carcinoma.",
              "image": null
            },
            {
              "id": "L12_Q12",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 10-year-old boy presents with multiple caf\u00e9-au-lait spots, axillary freckling, and neurofibromas. Which gene is most likely mutated?",
              "options": {
                "A": "NF1",
                "B": "NF2",
                "C": "TP53",
                "D": "BRCA1",
                "E": "APC"
              },
              "answer": "A",
              "explanation": "Neurofibromatosis type 1 is caused by NF1 mutations and is associated with caf\u00e9-au-lait spots and neurofibromas.",
              "image": null
            },
            {
              "id": "L12_Q13",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 35-year-old man with Peutz-Jeghers syndrome presents with mucocutaneous pigmentation and multiple GI polyps. Which cancer risk is increased?",
              "options": {
                "A": "Breast and pancreatic cancer",
                "B": "Glioblastoma",
                "C": "Lung cancer",
                "D": "Renal cell carcinoma",
                "E": "Osteosarcoma"
              },
              "answer": "A",
              "explanation": "Peutz-Jeghers syndrome increases risk for breast, pancreatic, and GI cancers.",
              "image": null
            },
            {
              "id": "L12_Q15",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 60-year-old man with multiple endocrine neoplasia type 1 (MEN1) is tested for mutation. Which gene is affected?",
              "options": {
                "A": "MEN1 (menin)",
                "B": "RET",
                "C": "TP53",
                "D": "NF1",
                "E": "BRCA2"
              },
              "answer": "A",
              "explanation": "MEN1 syndrome is caused by mutations in the MEN1 gene encoding menin.",
              "image": null
            },
            {
              "id": "L12_Q16",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 40-year-old woman with Cowden syndrome is tested for mutations. Which gene is involved?",
              "options": {
                "A": "PTEN",
                "B": "TP53",
                "C": "APC",
                "D": "RET",
                "E": "NF2"
              },
              "answer": "A",
              "explanation": "Cowden syndrome is caused by PTEN mutations and predisposes to breast, thyroid, and endometrial cancers.",
              "image": null
            },
            {
              "id": "L12_Q18",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 55-year-old woman with ovarian cancer has a family history of breast and prostate cancer. Which genetic counseling approach is recommended?",
              "options": {
                "A": "Single-gene testing only",
                "B": "Panel testing for hereditary cancer genes",
                "C": "No testing unless recurrence occurs",
                "D": "Exclude due to age",
                "E": "Only test BRCA1"
              },
              "answer": "B",
              "explanation": "Panel testing is appropriate in families with diverse cancer histories to capture multiple possible syndromes.",
              "image": null
            }
          ]
        },
        {
          "name": "Genetic Testing: Logistics",
          "question_count": 3,
          "long_questions": [
            {
              "id": "L12_Q14",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 45-year-old woman with suspected Lynch syndrome undergoes immunohistochemistry for mismatch repair proteins. Loss of staining is seen for MLH1. What is the next step?",
              "options": {
                "A": "Treat empirically as Lynch syndrome",
                "B": "Germline testing for MLH1",
                "C": "No further evaluation needed",
                "D": "Test for APC mutation",
                "E": "Ignore findings"
              },
              "answer": "B",
              "explanation": "Loss of protein expression on IHC should be followed by germline testing for confirmation.",
              "image": null
            },
            {
              "stem": "A case is suspected to involve Genetic Testing: Logistics within the broader topic of Genetic Counseling of Familial Cancers. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Integration of histology with molecular testing correlating with clinical context",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "B",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "A case is suspected to involve Genetic Testing: Logistics within the broader topic of Genetic Counseling of Familial Cancers. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Integration of histology with molecular testing correlating with clinical context",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "B",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Management of Pathogenic Variants",
          "question_count": 2,
          "long_questions": [
            {
              "id": "L12_Q10",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 42-year-old woman with breast cancer undergoes multigene panel testing. A VUS is detected in BRCA2. What is the correct management?",
              "options": {
                "A": "Treat as pathogenic",
                "B": "Ignore it completely",
                "C": "Do not use for clinical decisions",
                "D": "Recommend prophylactic oophorectomy",
                "E": "Use for family cascade testing"
              },
              "answer": "C",
              "explanation": "Variants of uncertain significance should not guide management until reclassified.",
              "image": null
            },
            {
              "id": "L12_Q19",
              "difficulty": "Hard",
              "long_form": true,
              "stem": "A 50-year-old woman with a BRCA1 mutation undergoes prophylactic bilateral mastectomy. This intervention is best described as:",
              "options": {
                "A": "Primary prevention",
                "B": "Secondary prevention",
                "C": "Tertiary prevention",
                "D": "Quaternary prevention",
                "E": "Palliative surgery"
              },
              "answer": "A",
              "explanation": "Risk-reducing mastectomy is primary prevention, as it prevents disease occurrence in high-risk individuals.",
              "image": null
            }
          ]
        },
        {
          "name": "Taking a Family History (Pedigree)",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Taking a Family History (Pedigree) within the broader topic of Genetic Counseling of Familial Cancers. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Reliance on imaging alone"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Taking a Family History (Pedigree), which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Evidence of invasion and metastatic potential",
                "B": "Lesion size alone",
                "C": "Patient age alone",
                "D": "Presence of inflammation"
              },
              "answer": "A",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "When to Suspect a Hereditary Syndrome",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve When to Suspect a Hereditary Syndrome within the broader topic of Genetic Counseling of Familial Cancers. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Serum tumor markers alone establish diagnosis",
                "B": "Integration of histology with molecular testing correlating with clinical context",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Reliance on imaging alone"
              },
              "answer": "B",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In When to Suspect a Hereditary Syndrome, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Presence of inflammation",
                "B": "Lesion size alone",
                "C": "Patient age alone",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Psychosocial and Ethical Issues",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Psychosocial and Ethical Issues within the broader topic of Genetic Counseling of Familial Cancers. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Reliance on imaging alone"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Psychosocial and Ethical Issues, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Evidence of invasion and metastatic potential",
                "B": "Patient age alone",
                "C": "Lesion size alone",
                "D": "Presence of inflammation"
              },
              "answer": "A",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        }
      ]
    },
    {
      "topic": "Gene Therapy",
      "subtopics": [
        {
          "name": "Definition and Core Approaches",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Definition and Core Approaches within the broader topic of Gene Therapy. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Reliance on imaging alone",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Definition and Core Approaches, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Patient age alone",
                "B": "Lesion size alone",
                "C": "Presence of inflammation",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Exon-Skipping Therapy",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Exon-Skipping Therapy within the broader topic of Gene Therapy. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Reliance on imaging alone",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Exon-Skipping Therapy, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Evidence of invasion and metastatic potential",
                "B": "Patient age alone",
                "C": "Presence of inflammation",
                "D": "Lesion size alone"
              },
              "answer": "A",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Somatic vs Germline Gene Therapy",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Somatic vs Germline Gene Therapy within the broader topic of Gene Therapy. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Reliance on imaging alone",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Somatic vs Germline Gene Therapy, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Presence of inflammation",
                "B": "Patient age alone",
                "C": "Evidence of invasion and metastatic potential",
                "D": "Lesion size alone"
              },
              "answer": "C",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Viral Vectors: Retroviral and Lentiviral",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Viral Vectors: Retroviral and Lentiviral within the broader topic of Gene Therapy. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Serum tumor markers alone establish diagnosis",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Reliance on imaging alone"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Viral Vectors: Retroviral and Lentiviral, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Patient age alone",
                "B": "Presence of inflammation",
                "C": "Evidence of invasion and metastatic potential",
                "D": "Lesion size alone"
              },
              "answer": "C",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Viral Vectors: Adenoviral and AAV",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Viral Vectors: Adenoviral and AAV within the broader topic of Gene Therapy. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Reliance on imaging alone"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Viral Vectors: Adenoviral and AAV, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Patient age alone",
                "B": "Lesion size alone",
                "C": "Presence of inflammation",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Non-Viral Delivery Systems",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Non-Viral Delivery Systems within the broader topic of Gene Therapy. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Reliance on imaging alone",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Exclusion of biopsy to avoid tumor spread"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Non-Viral Delivery Systems, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Presence of inflammation",
                "B": "Evidence of invasion and metastatic potential",
                "C": "Patient age alone",
                "D": "Lesion size alone"
              },
              "answer": "B",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Clinical Examples of Gene Therapy",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Clinical Examples of Gene Therapy within the broader topic of Gene Therapy. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Reliance on imaging alone",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Clinical Examples of Gene Therapy, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Evidence of invasion and metastatic potential",
                "B": "Patient age alone",
                "C": "Lesion size alone",
                "D": "Presence of inflammation"
              },
              "answer": "A",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Risks of Gene Therapy",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Risks of Gene Therapy within the broader topic of Gene Therapy. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Serum tumor markers alone establish diagnosis",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Reliance on imaging alone",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Risks of Gene Therapy, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Lesion size alone",
                "B": "Patient age alone",
                "C": "Presence of inflammation",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Ethical Considerations",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Ethical Considerations within the broader topic of Gene Therapy. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Integration of histology with molecular testing correlating with clinical context",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Reliance on imaging alone"
              },
              "answer": "B",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Ethical Considerations, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Patient age alone",
                "B": "Presence of inflammation",
                "C": "Lesion size alone",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Future Directions",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Future Directions within the broader topic of Gene Therapy. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Future Directions, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Patient age alone",
                "B": "Presence of inflammation",
                "C": "Lesion size alone",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        }
      ]
    },
    {
      "topic": "Cancer Survival Mechanisms (Hallmarks of Cancer)",
      "subtopics": [
        {
          "name": "Overview of Hallmarks",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Overview of Hallmarks within the broader topic of Cancer Survival Mechanisms (Hallmarks of Cancer). Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Reliance on imaging alone",
                "C": "Serum tumor markers alone establish diagnosis",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Overview of Hallmarks, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Presence of inflammation",
                "B": "Patient age alone",
                "C": "Lesion size alone",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Sustained Growth Signaling",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Sustained Growth Signaling within the broader topic of Cancer Survival Mechanisms (Hallmarks of Cancer). Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Sustained Growth Signaling, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Evidence of invasion and metastatic potential",
                "B": "Patient age alone",
                "C": "Presence of inflammation",
                "D": "Lesion size alone"
              },
              "answer": "A",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Evading Growth Suppressors",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Evading Growth Suppressors within the broader topic of Cancer Survival Mechanisms (Hallmarks of Cancer). Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Reliance on imaging alone",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Evading Growth Suppressors, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Lesion size alone",
                "B": "Presence of inflammation",
                "C": "Patient age alone",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Resisting Apoptosis",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Resisting Apoptosis within the broader topic of Cancer Survival Mechanisms (Hallmarks of Cancer). Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Integration of histology with molecular testing correlating with clinical context",
                "C": "Reliance on imaging alone",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "B",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Resisting Apoptosis, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Lesion size alone",
                "B": "Presence of inflammation",
                "C": "Evidence of invasion and metastatic potential",
                "D": "Patient age alone"
              },
              "answer": "C",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Enabling Replicative Immortality",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Enabling Replicative Immortality within the broader topic of Cancer Survival Mechanisms (Hallmarks of Cancer). Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Reliance on imaging alone"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Enabling Replicative Immortality, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Patient age alone",
                "B": "Evidence of invasion and metastatic potential",
                "C": "Lesion size alone",
                "D": "Presence of inflammation"
              },
              "answer": "B",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Inducing Angiogenesis",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Inducing Angiogenesis within the broader topic of Cancer Survival Mechanisms (Hallmarks of Cancer). Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Reliance on imaging alone",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Inducing Angiogenesis, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Lesion size alone",
                "B": "Presence of inflammation",
                "C": "Patient age alone",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Activating Invasion & Metastasis",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A patient with ovarian carcinoma has diffuse peritoneal nodules. What route of spread characterizes Activating Invasion & Metastasis?",
              "options": {
                "A": "Lymphatic spread to axillary nodes",
                "B": "Direct extension through the diaphragm",
                "C": "Hematogenous spread via portal system",
                "D": "Transcoelomic seeding within the peritoneal cavity"
              },
              "answer": "D",
              "explanation": "Ovarian carcinoma commonly spreads transcoelomically across peritoneal surfaces.",
              "difficulty": "medium"
            },
            {
              "stem": "Which tumor most classically spreads hematogenously (relevant to Activating Invasion & Metastasis)?",
              "options": {
                "A": "Renal cell carcinoma",
                "B": "In situ carcinoma",
                "C": "Cervical squamous cell carcinoma",
                "D": "Basal cell carcinoma"
              },
              "answer": "A",
              "explanation": "RCC often spreads via renal vein to IVC; many carcinomas are lymphatic by default.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Immune Evasion",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Immune Evasion within the broader topic of Cancer Survival Mechanisms (Hallmarks of Cancer). Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Reliance on imaging alone"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Immune Evasion, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Presence of inflammation",
                "B": "Patient age alone",
                "C": "Lesion size alone",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Altered Metabolism (Warburg Effect)",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Altered Metabolism (Warburg Effect) within the broader topic of Cancer Survival Mechanisms (Hallmarks of Cancer). Which principle most directly guides diagnosis?",
              "options": {
                "A": "Reliance on imaging alone",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Altered Metabolism (Warburg Effect), which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Evidence of invasion and metastatic potential",
                "B": "Patient age alone",
                "C": "Lesion size alone",
                "D": "Presence of inflammation"
              },
              "answer": "A",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Cancer Cachexia",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Cancer Cachexia within the broader topic of Cancer Survival Mechanisms (Hallmarks of Cancer). Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Reliance on imaging alone",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Cancer Cachexia, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Lesion size alone",
                "B": "Presence of inflammation",
                "C": "Patient age alone",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Tumor Heterogeneity and Cancer Stem Cells",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Tumor Heterogeneity and Cancer Stem Cells within the broader topic of Cancer Survival Mechanisms (Hallmarks of Cancer). Which principle most directly guides diagnosis?",
              "options": {
                "A": "Serum tumor markers alone establish diagnosis",
                "B": "Reliance on imaging alone",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Exclusion of biopsy to avoid tumor spread"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Tumor Heterogeneity and Cancer Stem Cells, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Presence of inflammation",
                "B": "Patient age alone",
                "C": "Lesion size alone",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        }
      ]
    },
    {
      "topic": "Individualizing Care of the Cancer Patient",
      "subtopics": [
        {
          "name": "Overview of Precision Medicine",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A biopsy shows full\u2011thickness epithelial atypia with an intact basement membrane. This best describes Overview of Precision Medicine. What is the correct classification?",
              "options": {
                "A": "Metaplasia",
                "B": "Invasive carcinoma",
                "C": "Hyperplasia without atypia",
                "D": "Carcinoma in situ"
              },
              "answer": "D",
              "explanation": "Full-thickness atypia without invasion is CIS.",
              "difficulty": "medium"
            },
            {
              "stem": "In Overview of Precision Medicine, which transition represents true invasion?",
              "options": {
                "A": "Higher mitotic rate",
                "B": "Breaching the basement membrane",
                "C": "Increasing nuclear:cytoplasmic ratio",
                "D": "Loss of polarity within epithelium"
              },
              "answer": "B",
              "explanation": "Invasion is defined by basement membrane breach; other changes are intraepithelial.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Biomarker-Driven Therapy",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Biomarker-Driven Therapy within the broader topic of Individualizing Care of the Cancer Patient. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Serum tumor markers alone establish diagnosis",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Integration of histology with molecular testing correlating with clinical context",
                "D": "Reliance on imaging alone"
              },
              "answer": "C",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Biomarker-Driven Therapy, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Evidence of invasion and metastatic potential",
                "B": "Presence of inflammation",
                "C": "Patient age alone",
                "D": "Lesion size alone"
              },
              "answer": "A",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "NGS and Liquid Biopsy",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A broad NGS panel is ordered for a lung adenocarcinoma. Compared with single\u2011gene NGS and Liquid Biopsy, what is the main advantage?",
              "options": {
                "A": "Cannot detect gene fusions",
                "B": "Direct measurement of protein phosphorylation states",
                "C": "Simultaneous detection of SNVs, indels, fusions, CNVs across many genes",
                "D": "Lower depth but faster than PCR"
              },
              "answer": "C",
              "explanation": "NGS enables multi-gene, multi-variant detection in parallel.",
              "difficulty": "medium"
            },
            {
              "stem": "A hotspot NGS and Liquid Biopsy assay is negative, but driver mutation is still suspected. What next?",
              "options": {
                "A": "Skip molecular testing",
                "B": "Repeat the same PCR with fewer cycles",
                "C": "Use Southern blot",
                "D": "Move to comprehensive NGS for broader variant coverage"
              },
              "answer": "D",
              "explanation": "NGS provides broader coverage and can detect non-hotspot or fusion events missed by single-gene PCR.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Oncotype Dx and Prognostic Panels",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A broad NGS panel is ordered for a lung adenocarcinoma. Compared with single\u2011gene Oncotype Dx and Prognostic Panels, what is the main advantage?",
              "options": {
                "A": "Simultaneous detection of SNVs, indels, fusions, CNVs across many genes",
                "B": "Lower depth but faster than PCR",
                "C": "Cannot detect gene fusions",
                "D": "Direct measurement of protein phosphorylation states"
              },
              "answer": "A",
              "explanation": "NGS enables multi-gene, multi-variant detection in parallel.",
              "difficulty": "medium"
            },
            {
              "stem": "A hotspot Oncotype Dx and Prognostic Panels assay is negative, but driver mutation is still suspected. What next?",
              "options": {
                "A": "Repeat the same PCR with fewer cycles",
                "B": "Use Southern blot",
                "C": "Move to comprehensive NGS for broader variant coverage",
                "D": "Skip molecular testing"
              },
              "answer": "C",
              "explanation": "NGS provides broader coverage and can detect non-hotspot or fusion events missed by single-gene PCR.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Stratified Medicine vs Precision Medicine",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A biopsy shows full\u2011thickness epithelial atypia with an intact basement membrane. This best describes Stratified Medicine vs Precision Medicine. What is the correct classification?",
              "options": {
                "A": "Metaplasia",
                "B": "Hyperplasia without atypia",
                "C": "Invasive carcinoma",
                "D": "Carcinoma in situ"
              },
              "answer": "D",
              "explanation": "Full-thickness atypia without invasion is CIS.",
              "difficulty": "medium"
            },
            {
              "stem": "In Stratified Medicine vs Precision Medicine, which transition represents true invasion?",
              "options": {
                "A": "Loss of polarity within epithelium",
                "B": "Breaching the basement membrane",
                "C": "Increasing nuclear:cytoplasmic ratio",
                "D": "Higher mitotic rate"
              },
              "answer": "B",
              "explanation": "Invasion is defined by basement membrane breach; other changes are intraepithelial.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Pharmacogenomics",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Pharmacogenomics within the broader topic of Individualizing Care of the Cancer Patient. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Integration of histology with molecular testing correlating with clinical context",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Reliance on imaging alone",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "A",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Pharmacogenomics, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Presence of inflammation",
                "B": "Lesion size alone",
                "C": "Evidence of invasion and metastatic potential",
                "D": "Patient age alone"
              },
              "answer": "C",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Genetic Counseling: Process",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Genetic Counseling: Process within the broader topic of Individualizing Care of the Cancer Patient. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Serum tumor markers alone establish diagnosis",
                "B": "Exclusion of biopsy to avoid tumor spread",
                "C": "Reliance on imaging alone",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Genetic Counseling: Process, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Lesion size alone",
                "B": "Patient age alone",
                "C": "Evidence of invasion and metastatic potential",
                "D": "Presence of inflammation"
              },
              "answer": "C",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Red Flags for Hereditary Cancer",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Red Flags for Hereditary Cancer within the broader topic of Individualizing Care of the Cancer Patient. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Serum tumor markers alone establish diagnosis",
                "B": "Reliance on imaging alone",
                "C": "Exclusion of biopsy to avoid tumor spread",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Red Flags for Hereditary Cancer, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Presence of inflammation",
                "B": "Evidence of invasion and metastatic potential",
                "C": "Lesion size alone",
                "D": "Patient age alone"
              },
              "answer": "B",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Variant of Uncertain Significance (VUS)",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Variant of Uncertain Significance (VUS) within the broader topic of Individualizing Care of the Cancer Patient. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Integration of histology with molecular testing correlating with clinical context",
                "C": "Reliance on imaging alone",
                "D": "Serum tumor markers alone establish diagnosis"
              },
              "answer": "B",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Variant of Uncertain Significance (VUS), which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Evidence of invasion and metastatic potential",
                "B": "Presence of inflammation",
                "C": "Lesion size alone",
                "D": "Patient age alone"
              },
              "answer": "A",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        },
        {
          "name": "Management of Pathogenic Variants",
          "question_count": 2,
          "long_questions": [
            {
              "stem": "A case is suspected to involve Management of Pathogenic Variants within the broader topic of Individualizing Care of the Cancer Patient. Which principle most directly guides diagnosis?",
              "options": {
                "A": "Exclusion of biopsy to avoid tumor spread",
                "B": "Serum tumor markers alone establish diagnosis",
                "C": "Reliance on imaging alone",
                "D": "Integration of histology with molecular testing correlating with clinical context"
              },
              "answer": "D",
              "explanation": "Best practice integrates morphology, molecular findings, and clinical data; imaging and markers are adjuncts.",
              "difficulty": "medium"
            },
            {
              "stem": "In Management of Pathogenic Variants, which of the following would best distinguish benign from malignant processes?",
              "options": {
                "A": "Presence of inflammation",
                "B": "Lesion size alone",
                "C": "Patient age alone",
                "D": "Evidence of invasion and metastatic potential"
              },
              "answer": "D",
              "explanation": "Malignancy is defined by invasion/metastasis rather than size or age alone.",
              "difficulty": "medium"
            }
          ]
        }
      ]
    }
  ]
}